UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2018
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT
 
For the transition period from N/A to N/A
Commission File No. 000-52369
 
FITLIFE BRANDS, INC.
(Name of small business issuer as specified in its charter)
 
Nevada
 
20-3464383
(State or other jurisdiction of incorporation)
 
(IRS Employer Identification No.)
                                                                                                         
  5214 S. 136th Street, Omaha, NE 68137
(Address of principal executive offices)
 
 (402) 991-5618
(Issuer’s telephone number)
 
(Former name, former address and former fiscal year, if changed since last report)
 
Indicate by check mark whether the Registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days:  Yes     No 
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes      No 
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filer
Accelerated filer
Non–Accelerated filer 
Small reporting company
 
 
Emerging growth company 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b–2 of the Exchange Act).  Yes      No 
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
Class
 
Outstanding at November 13, 2018
Common stock, $0.01 par value
 
11,084,545
 
 
 


 
 
 
 
FITLIFE B R ANDS, INC.
 INDEX TO FORM 10-Q FILING
FOR THE QUARTER ENDED SEPTEMBER 30, 2018
 
T ABLE OF CONTENTS
 
 
 
 
PAGE
 
 
 
 
 
 
 
1
 
 
 
 
 
 
1
 
 
2
 
 
3
 
 
4
 
 
5
 
 
 
 
 
12
 
 
 
 
 
16
 
 
 
 
 
17
 
 
 
 
18
 
 
 
 
 
18
 
 
 
 
 
18
 
 
 
 
 
18
 
 
 
 
 
18
 
 
 
 
 
18
 
 
 
 
 
19
 
 
 
-i-
 
 
Special Note Regarding Forward-Looking Statements
 
This Quarterly Report on Form 10-Q (“Quarterly Report”), including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2 of Part I of this report, includes forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by forward-looking statements.
 
In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “proposed,” “intended,” or “continue” or the negative of these terms or other comparable terminology. You should read statements that contain these words carefully, because they discuss our expectations about our future operating results or our future financial condition or state other “forward-looking” information. There may be events in the future that we are not able to accurately predict or control. Before you invest in our securities, you should be aware that the occurrence of any of the events described in this Quarterly Report could substantially harm our business, results of operations and financial condition, and that upon the occurrence of any of these events, the trading price of our securities could decline and you could lose all or part of your investment. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, growth rates, levels of activity, performance or achievements. We are under no duty to update any of the forward-looking statements after the date of this Quarterly Report to conform these statements to actual results.
 
 
 
 
-ii-
 
 
PA R T I
FINANCIAL INFORMATION
 
Item 1.  Financial Statements
 
FITLIFE BRANDS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
 
 
 
September 30,
 
 
December 31,
 
 
 
2018
 
 
2017
 
 
 
 
(Unaudited)
 
 
 
 
ASSETS:  
   
 
 
 
 
 
 
 
CURRENT ASSETS
 
 
 
 
 
 
   Cash
  $ 533,000  
  $ 1,262,000  
   Accounts receivable, net of allowance of doubtful accounts and sales returns of $707,000 and $1,264,000, respectively
       
       
     -  Trade
    686,000
 
    1,958,000
 
     -  Factored
    2,458,000  
    -  
   Inventories, net of allowance for obsolescence of $7,000 and $49,000, respectively
    2,949,000  
    2,874,000  
   Note receivable
    -  
    5,000  
   Prepaid expense
    235,000  
    221,000  
      Total current assets
    6,861,000  
    6,320,000  
 
       
       
PROPERTY AND EQUIPMENT, net
    204,000  
    296,000  
 
       
       
   Goodwill
    225,000  
    225,000  
   Security deposits
    10,000  
    22,000  
    TOTAL ASSETS
  $ 7,300,000  
  $ 6,863,000  
 
       
       
LIABILITIES AND STOCKHOLDERS' EQUITY:
       
       
 
       
       
CURRENT LIABILITIES:
       
       
   Accounts payable
  $ 2,871,000  
  $ 2,974,000  
   Accrued expense and other liabilities
    593,000  
    612,000  
   Secured payable to factor
    1,950,000  
    -  
   Line of credit
    -  
    1,950,000  
   Term loan agreement, current portion
    -  
    415,000  
      Total current liabilities
    5,414,000  
    5,951,000  
 
       
       
CONTINGENCIES AND COMMITMENTS
    -  
    -  
 
       
       
STOCKHOLDERS' EQUITY:
       
       
   Common stock, $0.01 par value, 150,000,000 shares authorized;
       
       
   11,084,545 and 10,681,710 issued and outstanding
       
       
   as of September 30, 2018 and December 31, 2017, respectively
    111,000  
    107,000  
   Additional paid-in capital
    31,230,000  
    31,013,000  
   Accumulated deficit
    (29,455,000 )
    (30,208,000 )
      Total stockholders' equity
  $ 1,886,000  
  $ 912,000  
 
       
       
    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
  $ 7,300,000  
  $ 6,863,000  
 
The accompanying notes are an integral part of these condensed consolidated financial statements
 
 
 
 
 
FITLIFE B R ANDS, INC.
 
 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
 
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018 AND 2017
 
 
 
    
    
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
September 30
 
 
September 30
 
 
 
2018
 
 
2017
 
 
2018
 
 
2017
 
 
(Unaudited)
(Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
 Revenue
  $ 4,583,000  
  $ 4,026,000  
  $ 13,576,000  
  $ 14,637,000  
 
       
       
       
       
 Cost of Goods Sold
    2,831,000  
    2,551,000  
    8,102,000  
    9,719,000  
 Gross Profit
    1,752,000  
    1,475,000  
    5,474,000  
    4,918,000  
 
       
       
       
       
OPERATING EXPENSE:
       
       
       
       
     General and administrative
    784,000  
    1,030,000  
    2,493,000  
    3,200,000  
     Selling and marketing
    547,000  
    829,000  
    2,070,000  
    2,690,000  
     Depreciation and amortization
    16,000  
    99,000  
    54,000  
    336,000  
         Total operating expense
    1,347,000  
    1,958,000  
    4,617,000  
    6,226,000  
OPERATING INCOME (LOSS)
    405,000  
    (483,000 )
    857,000  
    (1,308,000 )
 
       
       
       
       
OTHER EXPENSE
       
       
       
       
      Interest expense
    39,000  
    28,000  
    104,000  
    84,000  
      Other expense
    1,000  
    -  
    -  
    4,000  
        Total other expense
    40,000  
    28,000  
    104,000  
    88,000  
 
       
       
       
       
NET INCOME (LOSS)
  $ 365,000  
  $ (511,000 )
  $ 753,000  
  $ (1,396,000 )
 
       
       
       
       
NET INCOME (LOSS) PER SHARE:
       
       
       
       
  Basic and diluted
  $ 0.03  
  $ (0.05 )
  $ 0.07  
  $ (0.13 )
 
       
       
       
       
  Basic and diluted weighted average common shares
    11,007,958  
    10,537,805  
    10,896,589  
    10,483,144  
 
 
The accompanying notes are an integral part of these condensed consolidated financial statements

 
 
 
 
FITLIFE B R ANDS, INC.
 
 
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
 
 
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018
 
(Unaudited)

 
 
 
 
 
 
 
 
Additional
 
 
 
 
 
 
 
 
 
Common Stock
 
 
Paid-in
 
 
Accumulated
 
 
 
 
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Deficit
 
 
Total
 
DECEMBER 31, 2017
    10,681,710  
  $ 107,000  
  $ 31,013,000  
  $ (30,208,000 )
  $ 912,000  
 
       
       
       
       
       
Common stock issued for services
    402,835  
    4,000  
    132,000  
    -  
    136,000  
 
       
       
       
       
       
Fair value of options issued for services
    -  
    -  
    85,000  
    -  
    85,000  
 
       
       
       
       
       
Net income
    -  
    -  
    -  
    753,000  
    753,000  
 
       
       
       
       
       
September 30, 2018
    11,084,545  
    111,000  
    31,230,000  
    (29,455,000 )
    1,886,000  
 
The accompanying notes are an integral part of these condensed consolidated financial statements
 \
 
 
 
FITLIFE BRANDS, INC.
CONDENSED CONSOLIDATED ST A TEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018 AND 2017
 
 
      
 
 
2018
 
 
2017
 
 
 
    (Unaudited)        
 
  Net income (loss)
  $ 753,000  
  $ (1,396,000 )
 
 Adjustments to reconcile net income (loss) to net cash used in operating activities:
 
       
  Depreciation and amortization
    54,000  
    336,000  
  Allowance for doubtful accounts and product returns
    (557,000 )
    -
 
  Allowance for inventory obsolescence
    (42,000 )
    -
 
  Common stock issued for services
    136,000  
    82,000  
  Fair value of options issued for services
    85,000  
    33,000  
  Loss on disposal of assets
    34,000  
    5,000  
  Changes in operating assets and liabilities:
       
       
    Accounts receivable - trade
    1,829,000  
    (588,000 )
    Accounts receivable - factored
    (2,458,000 )
    -  
    Inventories
    (33,000 )
    887,000
 
    Prepaid expense
    (14,000 )
    (49,000 )
    Customer note receivable
    5,000  
    7,000  
    Security deposit
    12,000
 
    -  
    Accounts payable
    (103,000 )
    880,000  
    Accrued liabilities and other liabilities
    (19,000 )
    51,000  
          Net cash used in operating activities
    (318,000 )
  248,000  
 
       
       
CASH FLOWS FROM INVESTING ACTIVITIES:
       
       
    Purchase of property and equipment
    -  
    (20,000 )
    Proceeds from the sale of assets
    4,000  
    -  
          Net cash provided by (used in) investing activities
    4,000  
    (20,000 )
 
       
       
CASH FLOWS FROM FINANCING ACTIVITIES:
       
       
   Repayment of line of credit
    (1,950,000 )
    -  
   Secured payable to Factor
    1,950,000  
    -  
   Repayments of term loan
    (415,000 )
    (416,000 )
          Net cash used in financing activities
    (415,000 )
    (416,000 )
 
       
       
CHANGE IN CASH
    (729,000 )
    (188,000 )
CASH, BEGINNING OF PERIOD
    1,262,000  
    1,293,000  
CASH, END OF PERIOD
  $ 533,000  
  $ 1,105,000  
 
       
       
Supplemental disclosure operating activities
       
       
Cash paid for interest
  $ 104,000  
  $ 84,000  
 
       
       
Non-cash investing and financing activities
       
       
Cancellation of Treasury Stock
  $ -  
  $ 44,000  
 
The accompanying notes are an integral part of these condensed consolidated financial statements
 
 
 
 
FITLIFE B R ANDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018 AND 2017 (Unaudited)
 
NOTE 1 - DESCRIPTION OF BUSINESS
 
Summary
 
FitLife Brands, Inc. (the “ Company ”) is a national provider of innovative and proprietary nutritional supplements for health-conscious consumers marketed under the brand names NDS Nutrition Products™ ( www.ndsnutrition.com ), PMD ( www.pmdsports.com ), SirenLabs ( www.sirenlabs.com ), CoreActive ( www.coreactivenutrition.com ), and Metis Nutrition™ (www.metisnutrition.com) (together, “ NDS Products ”). With the consummation of the acquisition of iSatori, Inc. (“ iSatori ”) on October 1, 2015, the Company added several brands to its product portfolio, including iSatori ( www.isatori.com ), BioGenetic Laboratories, and Energize (together, “ iSatori Products ”). The NDS Products are distributed principally through franchised General Nutrition Centers, Inc. (“ GNC ”) stores located both domestically and internationally, and, with the addition of Metis Nutrition, through corporate GNC stores in the United States. The iSatori Products are sold through more than 25,000 retail locations, which include specialty, mass, and online.
 
The Company was incorporated in the State of Nevada on July 26, 2005. In October 2008, the Company acquired the assets of NDS Nutritional Products, Inc., a Nebraska corporation, and moved those assets into its wholly owned subsidiary NDS Nutrition Products, Inc., a Florida corporation (“ NDS ”). The Company’s NDS Products are sold through NDS and the iSatori Products are sold through iSatori, Inc., a Delaware corporation and a wholly owned subsidiary of the Company, which the Company acquired in October 2015.
 
The Company is headquartered in Omaha, Nebraska. For more information on the Company, please go to  http://www.fitlifebrands.com . The Company’s common stock currently trades under the symbol “FTLF” on the OTC:PINK market.
  
NOTE 2 - BASIS OF PRESENTATION
 
The accompanying interim condensed unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation are included. Operating results for the three and nine month periods ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018. Although management of the Company believes the disclosures presented herein are adequate and not misleading, these interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, as filed with the Securities and Exchange Commission on April 17, 2018.
  
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States (“ GAAP ”). Significant accounting policies are as follows: 
 
Principles of Consolidation
 
The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions have been eliminated in the consolidated condensed financial statements.
  
Use of Estimates
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and (iii) the reported amount of net sales and expense recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of financial statements; accordingly, actual results could differ from these estimates.
 
 
 
 
These estimates and assumptions also affect the reported amounts of accounts receivable, inventories, goodwill, revenue, costs and expense and valuations of long term assets, realization of deferred tax assets and fair value of equity instruments issued for services during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.  
 
Basic and Diluted Income (loss) Per Share
 
Our computation of earnings per share (“ EPS ”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an antidilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.
 
Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods because all warrants and stock options outstanding are anti-dilutive. At September 30, 2018 and 2017, we excluded the all outstanding options and warrants which entitle the holders thereof to acquire shares of common stock as their effect would have been anti-dilutive. The following securities that were excluded are as follows:
 
 
 
September
30, 2018
 
 
September
30, 2017
 
Options
    1,392,087  
    877,725  
Warrants
  -
    60,620  
Total
    1,392,087  
    938,345  
 
Goodwill
 
The Company had goodwill of $225,000, as of September 30, 2018 and December 31, 2017, respectively, as a result of the acquisition of NDS in October 2008. The Company adopted ASC Topic 350 – Goodwill and Other Intangible Assets . In accordance with ASC Topic 350, goodwill, which represents the excess of purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisition date. Under this standard, goodwill and intangibles with indefinite useful lives are no longer amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit’s goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value.
 
As of September 30, 2018 and December 31, 2017, there were no indicators of impairment for the recorded goodwill of $225,000, respectively. 
  
 Customer Concentration
 
Gross sales prior to reduction for vendor funded discounts and coupons to GNC during the nine month periods ended September 30, 2018 and 2017 were $12,732,000 and $15,569,000, respectively, representing 79% and 81% of total gross revenue, respectively.
 
Gross accounts receivable attributable to GNC as of September 30, 2018 and September 30, 2017 were $3,359,000 and $2,680,000 , respectively, representing 88% and 78% of the Company’s total accounts receivable balance, respectively.
 
 
 
 
 
  Revenue Recognition
 
The Company’s revenue is comprised of sales of nutritional supplements to consumers, primarily through GNC stores.
 
In September 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 (ASU No. 2014-09) regarding revenue recognition. The new standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods. The ASU became effective January 1, 2018.
 
Due to the nature of the products sold by the Company, the adoption of the new standard has had no quantitative effect on the financial statements. However, the guidance requires additional disclosures to help users of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized.
 
The Company previously recognized revenue when risk of loss transferred to our customers and collection of the receivable was reasonably assured, which generally occurs when the product is shipped. A product is not shipped without an order from the customer and credit acceptance procedures performed. The Company allows for returns within 30 days of purchase from end-users. Our customers, such as GNC, may return purchased products to the Company under certain circumstances, which include expired or soon to be expired products located in GNC corporate stores or at any of its distribution centers, and products that are subject to a recall or that contain an ingredient or ingredients that are subject to a recall by the U.S. Food and Drug Administration.
 
Under the new guidance, revenue is recognized when control of promised goods is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and costs of sales are recognized once products are delivered to the customer’s control and performance obligations are satisfied.
 
All products sold by the Company are distinct individual products and consist of nutritional supplements and related supplies. The products are offered for sale solely as finished goods, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Other than promotional activities, which can vary from time to time but nevertheless are entirely within the Company’s control, contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time.
 
Control of products we sell transfers to customers upon shipment from our facilities, and the Company’s performance obligations are satisfied at that time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than promised goods to the customer. Payment for sales are generally made by check, credit card, or wire transfer. Historically the Company has not experienced any significant payment delays from customers.
 
We provide a 30-day right of return for our products. A right of return does not represent a separate performance obligation, but because customers are allowed to return products, the consideration to which the Company expects to be entitled is variable. Upon evaluation of returns, the Company determined that substantially less than 5% of products are returned, and therefore believes it is probable that such returns will not cause a significant reversal of revenue in the future. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.
  
Income Taxes
 
As of September 30, 2017, the Company had Federal net operating loss (“ NOL ”) carry forwards available to offset future taxable income of approximately $28.0 million. Approximately $18.0 million of the NOL can be used in fiscal 2018, while the remaining $10.0 million can be used after fiscal 2018, subject to Internal Revenue Services (“ IRS ”) statutory limitations.
 
During the nine month period ended September 30, 2018, the Company reported income from operations of $857,000 and net income of $753,000. As a result of the Company’s significant NOL of approximately $28.0 million, which can be utilized starting in fiscal 2018, there was no provision for income tax recorded during the period ended September 30, 2018.
 
The Company accounts for income taxes using the asset and liability method, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized before the Company is able to realize their benefits, or that future deductibility is uncertain. Authoritative guidance issued by the ASC Topic 740 –  Income Taxes  requires that a valuation allowance be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As a result of the limitations related to Internal Revenue Code and the Company’s lack of history of profitable operations, the Company recorded a 100% valuation allowance against its net deferred tax assets as of September 30, 2018 and December 31, 2017.
 
 
 
In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment.
 
Recent Accounting Pronouncements
 
In February 2016, the FASB issued ASU No. 2016-02, Leases . This update will require the recognition of a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, for all leases with terms longer than 12 months. For operating leases, the asset and liability will be expensed over the lease term on a straight-line basis, with all cash flows included in the operating section of the statement of cash flows. For finance leases, interest on the lease liability will be recognized separately from the amortization of the right-of-use asset in the statement of comprehensive income and the repayment of the principal portion of the lease liability will be classified as a financing activity while the interest component will be included in the operating section of the statement of cash flows. ASU 2016-02 is effective for annual and interim reporting periods beginning after December 15, 2018. Early adoption is permitted. Upon adoption, leases will be recognized and measured at the beginning of the earliest period presented using a modified retrospective approach. The Company is currently evaluating the impact of the adoption of ASU 2016-02 on its financial statements and related disclosures.
 
Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.
 
NOTE 4 – MERCHANT AGREEMENT
 
In December 2017, the Company, through NDS and iSatori (together, the “ Subsidiaries ”) , entered into a Merchant Agreement with Compass Bank, d/b/a Commercial Billing Service (“ Compass ”) (“ Factor ”) . Under the terms of the Merchant Agreement, subject to the satisfaction of certain conditions to funding, the Subsidiaries agreed to sell to Compass, and Compass agreed to purchase from the Subsidiaries, certain accounts owing from customers of such Subsidiaries, including GNC. All amounts due under the terms of the Merchant Agreement, totaling up to $5.0 million, are guaranteed by the Company under the terms of a Continuing Guarantee. The Company pays a fee calculated based on the London Interbank Offering Rate (“ LIBOR ”) plus 550 basis points, which fee is based on the outstanding gross amount of accounts receivable factored in excess of total cash collected by Compass from customers against such amounts. The applicable LIBOR rate as of September 30, 2018 was 2.2%. Additionally, the Company is charged a non-utilization fee by which the average outstanding amount of obligations is less than $2.0 million, as amended. The Company has pledged collateral of all present and future inventory, accounts, accounts receivable, general intangibles and returned goods, together with all reserves, balances, deposits, and property at any time owing to the credit of the Company with Compass and any and all substitutions, accessions, additions, parts, accessories, attachments, replacements, proceeds and products of, for and to inventory, whether now or hereafter owned, existing, created, arising or acquired. The Merchant Agreement renews automatically unless either party terminates with a written notice within thirty days of the anniversary date.
 
Under the terms of the Merchant Agreement, all factored receivables are sold with recourse, which requires the Company to repurchase any receivables, if demanded, not paid on time causing such receivables to be accounted for as a secured financing arrangement and not as a sale of financial assets. Receivables are presented net of allowance for doubtful accounts with the recourse amount potentially due Compass in the event of untimely payment presented under current liabilities as a secured financing obligation. There were no invoices factored under this Merchant Agreement during the year ended December 31, 2017.
 
During the nine-month period ended September 30, 2018, the Company sold to Factor, on a recourse basis, an aggregate of $11,448,000 of invoices, net of credit memos, for cash proceeds of $10,840,000. In addition, the Company also incurred fees and other charges in the aggregate amount of $100,000, which was reflected as part of interest expense in the accompanying statement of operations. As of September 30, 2018, total due from Factor amounted to $508,000, which represents the 20% holdback for invoices it had not yet collected.
 
For financial statement presentation purposes, as the receivables were sold with recourse, the Company reflected the amount due from Factor on the accompanying balance sheet as follows:
 
Accounts Receivable - Factor
  $ 2,458,000  
Secured Payable to Factor
    (1,950,000 )
   Total
  $ 508,000  
 
NOTE 5 – INVENTORIES
 
The Company’s inventories as of September 30, 2018 and December 31, 2017 were as follows:
 
 
 
September 30,
2018 (unaudited)
 
 
December 31,
2017
 
Finished goods
  $ 2,446,000  
  $ 2,511,000  
Components
    510,000  
    412,000  
Allowance for obsolescence
    (7,000 )
    (49,000 )
Total
  $ 2,949,000  
  $ 2,874,000  



 
  
 
 
NOTE 6 - PROPERTY AND EQUIPMENT
 
The Company’s fixed assets as of September 30, 2018 and December 31, 2017 were as follows:
 
 
 
September 30,
2018 (unaudited)
 
 
December 31,
2017
 
Equipment
  $ 902,000  
  $ 973,000  
Accumulated depreciation
    (698,000 )
    (677,000 )
Total
  $ 204,000  
  $ 296,000  
 
Depreciation expense for the nine months ended September 30, 2018 and 2017 was $54,000 and $40,000, respectively.
 
NOTE 7 – NOTES PAYABLE
 
The Company had previously obtained a line of credit (“ LOC ”) of $3.0 million and a separate term loan of $2.6 million (the “ Term Note ”) with U.S. Bank. Both the LOC and the Term Note were secured by the Company’s tangible and intangible assets, and had an average interest rate of 5% per annum. The LOC, as amended, matured in December 2017, while the Term Note did not mature until August 2018. As of December 31, 2017, the outstanding balance of these notes payable totaled $2,365,000 and was deemed in default due to non-compliance with certain financial covenants.
 
In January 2018, the Company paid U.S. Bank a total of $2,365,000 to settle the outstanding balance of the LOC and the Term Note. As of September 30, 2018, the LOC and Term Note had been fully paid.
 
 
 
 
NOTE 8 - EQUITY
 
Common Stock
 
The Company is authorized to issue 150 million shares of common stock, $0.01 par value, of which 11,084,545 shares of common stock were issued and outstanding as of September 30, 2018.
 
During the nine-month period ended September 30, 2018, the Company issued 402,835 shares of common stock with a fair value of $128,000 to employees and directors for services rendered. The shares were valued at their respective date of issuances.
 
In July 2018, in connection with the appointment of Mr. Dayton Judd as Chief Executive Officer, the Company granted Mr. Judd an aggregate of 450,000 shares of restricted common stock, which include vesting conditions subject to the achievement of certain market prices of the Company’s common stock. Such shares are also subject to forfeiture in the event Mr. Judd resigns from his position or is terminated by the Company. As the vesting of the 450,000 shares of restricted common stock is subject to certain market conditions, pursuant to current accounting guidelines, the Company determined the fair value to be $105,000, computed using the Monte Carlo simulations on a binomial model with the assistance of a valuation specialist with a derived service period of three years. During the period ended September 30, 2018, the Company recorded compensation expense of $8,000 to amortize the fair value of these restricted common shares based upon the prorated derived service period.
 
Preferred Stock
 
As of September 30, 2018, the Company was authorized to issue 10 million shares of Series A Convertible Preferred Stock, $0.01 par value (“ Series A Preferred ”), 1,000 shares of its 10% Cumulative Perpetual Series B Preferred Stock, $0.01 par value (“ Series B Preferred ’), and 500 shares of its Series C Convertible Preferred Stock, par value $0.01 (“ Series C Preferred ”), none of which were issued and outstanding as of September 30, 2018 and December 31, 2017.
 
Subsequent to the quarter ended September 30, 2018, the Company filed Certificates of Withdrawal with the Secretary of State of the State of Nevada for the Series A Preferred, Series B Preferred and Series C Preferred, thereby withdrawing each of the series of preferred stock and returning all previously designated shares to their status as authorized preferred stock available for issuance. Subsequent to the filing of the Certificates of Withdrawal, the Company filed a new Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock, $0.01 par value, designating 1,000 shares of the Company’s preferred stock as Series A Convertible Preferred. For additional information regarding the withdrawal of the Series A Preferred, Series B Preferred and Series C Preferred and the creation of the new Series A Convertible Preferred, see Note 10 – Subsequent Events .
  
Options
 
As of September 30, 2018 and December 31, 2017, 1,392,087 and 870,284 options to purchase shares of common stock of the Company were issued and outstanding, respectively. Additional information regarding options outstanding as of September 30, 2018 is as follows:  
 
 
 
Number of Options
 
December 31, 2017
    870,284  
Granted
    705,000  
Exercised
  -
Forfeited
    (183,197 )
September 30, 2018
    1,392,087  
Vested and exercisable
    919,577  
 
During the nine months ended September 30, 2018, the Company granted stock options to an officer to purchase 705,000 shares of Company common stock. The stock options are exercisable at a price of $0.28 per share, expire in ten years and vest as follows: one-third vested immediate upon issuance, and the remainder vest equally in equal annual installments over a period of two years from grant date. Total fair value of these options at grant date was approximately $147,000, which was determined using the Black-Scholes Option Pricing model with the following assumption: stock price of $0.28 per share, expected term of six years, volatility of 88%, dividend rate of 0% and risk free interest rate of 2.92%. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award; the expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; and the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future.
 
Outstanding
 
Exercise Price
 
Issuance Date
 
Expiration Date
 
Vesting
                     705,000
 
 $ 0.28
 
07/31/18
 
07/31/28
 
Yes
                     211,710
 
 $ 1.39
 
05/09/16
 
05/09/21
 
Yes
                       40,000
 
 $ 2.20
 
04/11/14
 
04/11/19
 
No
                     360,000
 
 $ 2.30
 
02/23/15
 
02/23/20
 
No
                       11,571
 
 $ 3.31
 
02/16/12
 
02/16/22
 
No
                       13,491
 
 $ 4.62
 
05/13/15
 
05/13/25
 
Yes
                       21,939
 
 $ 5.89
 
03/23/15
 
03/23/25
 
Yes
                         8,660
 
 $ 12.13
 
09/17/13
 
09/17/23
 
Yes
                         2,396
 
 $ 12.99
 
11/14/12
 
09/27/22
 
No
                       17,320
 
 $ 14.43
 
01/16/13
 
11/30/22
 
No
                  1,392,087
 
 
 
 
 
 
 
 
 
 
 
During the nine-month periods ended September 30, 2018 and 2017, the Company recognized compensation expense of $85,000 and $33,000, respectively, to account for the fair value of stock options that vested during the period.
 
Total intrinsic value of outstanding stock options as of September 30, 208 amounted to $91,000. Future unamortized compensation expense on the unvested outstanding options at September 30, 2018 amounted to $111,000, which will be recognized through May 2020.
 
Warrants
 
Total outstanding warrants to purchase shares of Company common stock as of December 31, 2017 amounted to 60,620 shares.
 
During the period ended September 30, 2018, all 60,620 warrants expired unexercised. As of September 30, 2018, there were no warrants issued and outstanding.
 
NOTE 9 – COMMITMENTS AND CONTINGENCIES
 
Legal Proceedings
 
On December 31, 2014, various plaintiffs, individually and on behalf of a purported nationwide and sub-class of purchasers, filed a lawsuit in the U.S. District Court for the Northern District of California, captioned  Ryan et al. v. Gencor Nutrients, Inc. et al. , Case No.: 4:14-CV-05682. The lawsuit includes claims made against the manufacturer and various producers and sellers of products containing a nutritional supplement known as Testofen, which is manufactured and sold by Gencor Nutrients, Inc. (“ Gencor ”). Specifically, the Ryan plaintiffs allege that various defendants have manufactured, marketed and/or sold Testofen, or nutritional supplements containing Testofen, and in doing so represented to the public that Testofen had been clinically proven to increase free testosterone levels. According to the plaintiffs, those claims are false and/or not statistically proven. Plaintiffs seek relief under violations of the Racketeering Influenced Corrupt Organizations Act, breach of express and implied warranties, and violations of unfair trade practices in violation of California, Pennsylvania, and Arizona law. NDS utilizes Testofen in a limited number of nutritional supplements it manufactures and sells pursuant to a license agreement with Gencor.
 
On February 19, 2015, this matter was transferred to the Central District of California to the Honorable Manuel Real. Judge Real had previously issued an order dismissing a similar lawsuit that had been filed by the same lawyer who represents the plaintiffs in the Ryan matter. The United States Court of Appeals reversed part of the dismissal issued by Judge Real and remanded the case back down to the district court for further proceedings. As a result, the parties in the Ryan matter issued a joint status report and that matter is again active.
  
We are currently not involved in any litigation except as noted above, that we believe could have a material adverse effect on our financial condition or results of operations. Other than described above, there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or any of its subsidiaries, threatened against or affecting the Company, our common stock, any of our subsidiaries or of the Company’s or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.
 
NOTE 10 – SUBSEQUENT EVENTS
 
Creation of a New Series A Convertible Preferred Stock
 
On November 13, 2018, the Company filed a new Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock (the “ Certificate of Designations ”) with the Secretary of State of the State of Nevada, designating 1,000 shares of the Company’s preferred stock as Series A Convertible Preferred Stock, $0.01 par value (the “ New Series A Preferred ”). Shares of the New Series A Preferred have a stated value of $1,000 per share (“ Stated Value ”), subject to certain adjustments, and accrue dividends annually at a rate of 12%, which dividends compound monthly and shall be paid quarterly, at the Company’s election, in either cash or shall accrue and increase the Stated Value of the Series A Preferred. Shares of the New Series A Preferred rank senior to the Company’s common stock.
 
Each share of the New Series A Preferred has a liquidation preference equal to the Stated Value plus all accrued and unpaid dividends (the “ Liquidation Preference ”), and is convertible into that number of shares of the Company’s common stock equal to the Liquidation Preference divided by $0.46 (the “ Conversion Shares ”). Holders of New Series A Preferred may elect to convert shares of New Series A Preferred into Conversion Shares at any time. The Company, at its sole option, may choose to redeem all or a portion of New Series A Preferred at any time for 115% of the Liquidation Preference per share (the “ Redemption Price ”); provided, however , in the event of a Change of Control (as such term is defined in the Certificate of Designations), the Company shall be required to redeem all issued and outstanding shares of New Series A Preferred for the Redemption Price.
 
Holders of New Series A Preferred will have the right to vote, on an as-converted basis, with the holders of the Company’s common stock on any matter presented to the Company’s stockholders for their action or consideration. So long as any shares of New Series A Preferred remain outstanding, holders of the Series A Preferred will have the right to elect one director to the Company’s Board of Directors (“ Board ”) (the “ Series A Director ”); provided, however , so long as Dayton Judd remains on the Company’s Board, he shall be deemed to be the Series A Director. Furthermore, so long as any shares of New Series A Preferred remain outstanding, the Company may not, without the affirmative vote or consent of at least 50% of the shares of issued and outstanding New Series A Preferred on such date, voting as a separate class, (i) authorize, create, issue or alter any class of debt or equity securities ranking pari passu or senior to the New Series A Preferred; (ii) amend provisions of the New Series A Preferred; (iii) repurchase, redeem or pay dividends on any class of junior securities, subject to certain exceptions; (iv) amend the Company’s Articles of Incorporation or Bylaws in any way that will have a material adverse effect on the rights of the New Series A Preferred; (v) after February 16, 2019, increase the size of the Board to more than five members; (vi) take any action that would constitute a Fundamental Transaction (as such term is defined in the Certificate of Designations); or (vii) incur any additional indebtedness other than through the Company’s Merchant Agreement, any other line of credit with Compass or under any similar replacement facility.
 
In addition, holders of the New Series A Preferred shall have certain piggyback registration rights for the first two years following November 13, 2018, and certain demand registration rights thereafter, as more specifically set forth in the Certificate of Designations.
 
New Series A Preferred Financing
 
On November 13, 2018, the Company entered into subscription agreements (the “ Subscription Agreements ”) with certain accredited investors (each, a “Purchaser ” and together, the “ Purchasers ”), pursuant to which the Company offered and sold to the Purchasers an aggregate of 600 units (“ Units ”) for $1,000 per Unit, with each Unit consisting of one share of New Series A Preferred and a warrant to purchase that number of shares of Company common stock equal to 30% of the shares of Company common stock issuable upon conversion of the New Series A Preferred purchased by the Purchaser (“ Warrant ”) (the “ Offering ”). The Warrants shall expire five years from the date of issuance, and are exercisable at a price of $0.46 per share. Warrants to purchase an aggregate of 391,304 shares of Company common stock were issued in the Offering.
 
The Offering resulted in gross proceeds to the Company of $600,000. Purchasers in the Offering included Dayton Judd, the Company’s Chairman and Chief Executive Officer, and Grant Dawson, a director. A portion of the Offering was also sold to an unaffiliated third party.
 
 
 
ITEM 2.  MANA G EMENT’S DISCUSSION AND   ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes appearing elsewhere in this Quarterly Report. This discussion and analysis may contain forward-looking statements based on assumptions about our future business.
 
Overview
 
FitLife Brands, Inc. (the “ Company ”) is a national provider of innovative and proprietary nutritional supplements for health-conscious consumers marketed under the brand names NDS Nutrition Products ( www.ndsnutrition.com ), PMD ( www.pmdsports.com ), SirenLabs ( www.sirenlabs.com ), CoreActive™ ( www.coreactivenutrition.com ), and Metis Nutrition (www.metisnutrition.com) (together, “ NDS Products ”). With the consummation of the merger with iSatori, Inc. (“ iSatori ”) on September 30, 2015, which became effective on October 1, 2015, described below (the “ Merger ”), the Company added several brands to its product portfolio, including iSatori ( www.isatori.com ), BioGenetic Laboratories, and Energize (together, “ iSatori Products ”). The NDS Products are distributed principally through franchised General Nutrition Centers, Inc. (“ GNC ”) stores located both domestically and internationally, and, with the addition of Metis Nutrition, through corporate GNC stores in the United States. The iSatori Products are sold through more than 25,000 retail locations, which include specialty, mass, and online.
 
The Company was incorporated in the State of Nevada on July 26, 2005. In October 2008, the Company acquired the assets of NDS Nutritional Products, Inc., a Nebraska corporation, and moved those assets into its wholly owned subsidiary NDS Nutrition Products, Inc., a Florida corporation (“ NDS ”). The Company’s NDS Products are sold through NDS and the iSatori Products are sold through iSatori, Inc., a Delaware corporation and a wholly owned subsidiary of the Company.
 
FitLife Brands is headquartered in Omaha, Nebraska. For more information on the Company, please go to http://www.fitlifebrands.com . The Company’s common stock currently trades under the symbol “FTLF” on the OTC:PINK market.
 
Results of Operations
 
Comparison of the Three and Nine months Ended September 30, 2018 to the Three and Nine months Ended September 30, 2017
  
Net Sales.   Revenue for the three months ended September 30, 2018 increased 14% to $4,583,000 as compared to   $4,026,000 for the three months ended September 30, 2017. Revenue for the nine months ended September 30, 2018 decreased 7% to $13,576,000 as compared to $14,637,000 for the nine months ended September 30, 2017. Revenue for the three- and nine-month periods ended September 30, 2018 compared to the prior three and nine-month periods, in part, reflects declining traffic trends and lower unit sales at retail locations leading to lower same store sales in GNC, our principal distribution channel, as well as certain inventory level adjustments by GNC resulting from such trends. Declining sales at retail locations during the three and nine months ended September 30, 2018 were partially offset by an increase in online sales. As a result of the macro issues affecting retail generally, management is focused on developing its omnichannel product sales capability through its retail partners and online through ecommerce platforms to drive additional incremental sales. Although sales derived from such channels were not material as a percentage of total sales during the three and nine-month periods ended September 30, 2018, management believes that its online channels will provide growth opportunities in the long-term.
  
Cost of Goods Sold.   Cost of goods sold for the three months ended September 30, 2018 increased to $2,831,000 as compared to $2,551,000 for the three months ended September 30, 2017. The increase during the three-month period is principally attributable to higher total sales volumes. Cost of goods sold for the nine months ended September 30, 2018 decreased to $8,102,000 as compared to $9,719,000 for the nine months ended September 30, 2017. The decrease during the nine-month period is principally attributable to lower sales in the period.
 
Gross Profit Margin.   Gross profit for the three months ended September 30 2018 increased to $1,752,000 as compared to $1,475,000 for the three months ended September 30, 2017. Gross profit for the nine months ended September 30, 2018 increased to $5,474,000 as compared to $4,918,000 for the nine months ended September 30, 2017. The increase during the three- and nine-month period is principally attributable to reduced returns and vendor funded discounts, which contributed to an increase in gross margin.
 
 
 
Gross margin for the three and nine months ended September 30, 2018 increased to 38.2% and 40.3%, respectively, from 36.6% and 33.6% for the comparable three- and nine-month periods last year, respectively. The increase in gross margin was primarily attributable to materially lower vendor funded discounts, reduced write-off activity and sales mix.
 
General and Administrative Expense. General and administrative expense for the three months ended September 30, 2018 decreased to $784,000 as compared to $ 1,030,000 for the three months ended September 30, 2017. The decrease in general and administrative expense for the three months ended September 30, 2018 is principally attributable to ongoing cost reduction initiatives, subletting certain facilities and lower headcount. General and administrative expense for the nine months ended September 30, 2018 decreased to $2,493,000 as compared to $3,200,000 for the nine months ended September 30, 2017. The decrease in general and administrative expense for the nine months ended September 30, 2018 is similarly attributable to ongoing cost reduction initiatives, reduced facilities expense and lower total headcount.
    
Selling and Marketing Expense.   Selling and marketing expense for the three months ended September 30, 2018 decreased to $547,000 as compared to $829,000 for the three months ended September 30, 2017. Selling and marketing expense for the nine months ended September 30, 2018 decreased to $2,070,000 as compared to $2,690,000 for the nine months ended September 30, 2017. The decrease in selling and marketing expense for the three and nine month periods ended September 30, 2018 is principally the result of budgetary controls.
 
Depreciation and Amortization .  Depreciation and amortization for the three months ended September 30, 2018 decreased to $16,000 as compared to $ 99,000 for the three months ended September 30, 2017. Depreciation and amortization for the nine months ended September 30, 2018 decreased to $54,000 as compared to $ 336,000 for the nine months ended September 30, 2017. The decrease in both periods was primarily attributable to decrease in amortization expense due to the write-off of certain intangible assets during the fourth quarter of 2017.
 
Net Income/(Loss).   We generated a net income of $365,000 for the three-month period ended September 30, 2018 as compared to a net loss of $(511,000) for the three months ended September 30, 2017. We generated a net income of $753,000 for the nine-month period ended September 30, 2018 as compared to a net loss of $(1,396,000) for the nine months ended September 30, 2017. The change from a net loss to net income for the three- and nine-month periods ended September 30, 2018 compared to the comparable periods last year is principally attributable to stronger margins and reduced operating expense, which offset lower sales volumes. 
    
Liquidity and Capital Resources    
 
At September 30, 2018, we had positive working capital of approximately $1,447,000, compared to $369,000 at December 31, 2017. Our principal sources of liquidity at September 30, 2018 consisted of $533,000 of cash and $686,000 from accounts receivable. The increase in working capital is principally attributable to the payment of the line of credit and term loan, both of which were current liabilities at December 31, 2017.
 
On November 13, 2018, subsequent to the quarter ended September 30, 2018, the Company offered and sold equity securities to certain accredited investors in a private placement transaction, as more specifically set forth in Part II Item 5 hereto, resulting in gross proceeds to the Company of $600,000.
  
The Company has historically financed its operations primarily through cash flow from operations and equity and debt financings, and more recently, the factoring of accounts receivable. The Company has also provided for its cash needs by issuing common stock, options and warrants for certain operating costs, including consulting and professional fees. The Company currently anticipates that cash derived from operations and existing cash resources, including the cash received by the Company as a result of the recent financing as well as through the Merchant Agreement with Compass, will be sufficient to provide for the Company’s liquidity for the next 12 months.
 
In December 2017, the Company, through its Subsidiaries, entered into the Merchant Agreement with Compass (“ Factor ”) described in Note 4 to the Condensed Consolidated Financial Statements included in this Quarterly Report. Under the terms of the Merchant Agreement, subject to the satisfaction of certain conditions to funding, the Subsidiaries agreed to sell to Compass, and Compass agreed to purchase from the Subsidiaries, certain accounts owing from customers of such Subsidiaries, including GNC. On January 22, 2018, the Subsidiaries sold to Compass accounts receivable under the Merchant Agreement aggregating approximately $2.0 million, the proceeds from which were used to pay U.S. Bank, inclusive of a payment of approximately $360,000 from the Company, all principal and accrued interest due and owed U.S. Bank under the Term Note and LOC described in Note 7 to the Condensed Consolidated Financial Statements included in this Quarterly Report. The Merchant Agreement is subject to an annual renewal process, which the Company expects will be completed during the fourth quarter of the 2018 fiscal year. No assurances can be given that the Merchant Agreement will be renewed for an additional year.
 
The Company is dependent on cash flow from operations and the accumulation of additional receivables available to sell to Compass under the terms of the Merchant Agreement to satisfy its working capital requirements. No assurances can be given that cash flow from operations and/or that the Company will have access to additional capital under the terms of the Merchant Agreement necessary to provide for the Company’s liquidity for the next twelve months. Should the Company be unable to generate sufficient revenue in the future to achieve positive cash flow from operations, and/or should capital be unavailable under the terms of the Merchant Agreement, additional working capital will be required. Management at present has no intention to raise additional working capital through the sale of equity or debt securities and believes the agreement with Compass, along with the proceeds of our recent capital raise, will provide sufficient capital necessary to operate the business over the next twelve months. In the event the Company fails to achieve positive cash flow from operations, additional capital is unavailable under the terms of the Merchant Agreement, and management is otherwise unable to secure additional working capital through the issuance of equity or debt securities, the Company’s business would be materially and adversely harmed.  
 
 
 
During the nine-month period ended September 30, 2018, the Company sold to Factor, on a recourse basis, an aggregate of $11,448,000 of invoices, net of credit memos, for cash proceeds of $10,840,000. In addition, the Company also incurred fees and other charges in the aggregate of $100,000, which was reflected as part of interest expense. Approximately $2.0 million of the proceeds were used to pay U.S. Bank, inclusive of a payment of approximately $360,000 from the Company, all principal and accrued interest due and owed U.S. Bank under the Term Note and LOC described in Note 7 to the Condensed Consolidated Financial Statements included in this Quarterly Report.  
 
Cash Used in Operations.  Our cash used in operating activities for the nine months ended September 30, 2018 was $318,000, as compared to $248,000 for the nine months ended September 30, 2017. The increase is principally attributable to variations in certain working capital accounts resulting from our agreement with Compass. Net working capital decreased to $1,447,000 as of the quarter ended September 30, 2018 compared to $2,206,000 as of September 30, 2017.
 
Cash Provided by (Used in) Investing Activities.   Cash provided by investing activities for the nine months ended September 30, 2018 was $4,000, as compared to $(20,000) used in investing activities for the nine months ended September 30, 2017.  
  
Cash Used in Financing Activities. Cash used in financing activities for the nine months ended September 30, 2018 was $(415,000) as compared to cash used in financing activities of $(416,000) during the nine months ended September 30, 2017. The primary difference between the 2018 and 2017 periods was the payoff of all amounts owed to U.S. Bank under both the LOC and Term Note during the nine months ended September 30, 2018, plus the impact of the factoring arrangement with Compass.
 
Critical Accounting Policies and Estimates
 
Our discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, expense, and related disclosure of contingent assets and liabilities. We evaluate, on an on-going basis, our estimates and judgments, including those related to the useful life of the assets. We base our estimates on historical experience and assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
 
The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results that we report in our consolidated financial statements. The SEC considers an entity’s most critical accounting policies to be those policies that are both most important to the portrayal of a company’s financial condition and results of operations and those that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about matters that are inherently uncertain at the time of estimation. For a more detailed discussion of the accounting policies of the Company, see Note 3 of the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report, “ Summary of Significant Accounting Policies .”
 
We believe the following critical accounting policies, among others, require significant judgments and estimates used in the preparation of our consolidated financial statements. 
 
Use of Estimates
 
              The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“ GAAP ”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and (iii) the reported amount of net sales and expense recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of financial statements; accordingly, actual results could differ from these estimates.
  
  These estimates and assumptions also affect the reported amounts of accounts receivable, inventories, goodwill, revenue, costs and expense and valuations of long term assets, allowance for deferred tax assets and equity instruments issued for services during the reporting period. Management evaluates these estimates and assumptions on a regular basis.  Actual results could differ from those estimates.  
 
 
 
 
Goodwill
 
The Company had goodwill with a carrying value of $225,000 as of September 30, 2018 and December 31, 2017, respectively, as a result of the acquisition of NDS in October 2008. The Company adopted ASC Topic 350 – Goodwill and Other Intangible Assets . In accordance with ASC Topic 350, goodwill, which represents the excess of purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisition date. Under this standard, goodwill and intangibles with indefinite useful lives are no longer amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit’s goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value.
 
Identifiable intangible assets are stated at cost and accounted for based on whether the useful life of the asset is finite or indefinite. Identified intangible assets with finite useful lives are amortized using the straight-line methods over their estimated useful lives, which was originally ten years. Intangible assets with indefinite lives are not amortized to operations, but instead are reviewed for impairment at least annually, or more frequently if there is an indicator of impairment.
 
As of September 30, 2018 and December 31, 2017, there were no indicators of impairment for the recorded goodwill of $225,000, respectively. 
 
Share Based Payment
 
             The Company issues stock options, warrants and common stock as share-based compensation to employees and non-employees. The Company accounts for its share-based compensation to employees in accordance with FASB ASC718 “ Compensation - Stock Compensation .” Stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service period.
 
 The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50 “ Equity - Based Payment to Non-Employees .” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received, or (b) the equity instruments issued. The final fair value of the share-based payment transaction is determined at the performance completion date. For interim periods, the fair value is estimated and the percentage of completion is applied to that estimate to determine the cumulative expense recorded.
 
 The Company values stock compensation based on the market price on the measurement date. For employees this is the date of grant, and for non-employees, this is the date of performance completion. The Company values stock options and warrants using the Black-Scholes option pricing model.
  
Revenue Recognition
 
The Company’s revenue is comprised of sales of nutritional supplements to consumers, primarily through GNC stores.
 
In September 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 (ASU No. 2014-09) regarding revenue recognition. The new standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services. The ASU became effective January 1, 2018.
 
Due to the nature of the products sold by the Company, the adoption of the new standard has had no quantitative effect on the financial statements. However, the guidance requires additional disclosures to help users of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized.
 
 
 
 
The Company previously recognized revenue when risk of loss transferred to our customers and collection of the receivable was reasonably assured, which generally occurs when the product is shipped. A product is not shipped without an order from the customer and credit acceptance procedures performed. The Company allows for returns within 30 days of purchase from end-users. GNC may return purchased products to the Company under certain circumstances, which include expired or soon to be expired products located in GNC corporate stores or at any of its distribution centers, and products that are subject to a recall or that contain an ingredient or ingredients that are subject to a recall by the FDA.
 
Under the new guidance, revenue is recognized when control of promised goods is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and costs of sales are recognized once products are delivered to the customer’s control and performance obligations are satisfied.
 
All products sold by the Company are distinct individual products and consist of nutritional supplements and related supplies. The products are offered for sale solely as finished goods, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Other than promotional activities, which can vary from time to time but nevertheless are entirely within the Company’s control, contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time.
 
Control of products we sell transfers to customers upon shipment from our facilities, and the Company’s performance obligations are satisfied at that time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than promised goods to the customer. Payment for sales are generally made by check, credit card, or wire transfer. Historically the Company has not experienced any significant payment delays from customers.
 
We provide a 30-day right of return for our products. A right of return does not represent a separate performance obligation, but because customers are allowed to return products, the consideration to which the Company expects to be entitled is variable. Upon evaluation of returns, the Company determined that substantially less than 5% of products are returned, and therefore believes it is probable that such returns will not cause a significant reversal of revenue in the future. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.
 
Recent Accounting Pronouncements
 
See Note 3 of the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report for a description of recent accounting pronouncements believed by management to have a material impact on our present or future financial statements.
 
WHERE YOU CAN FIND MORE INFORMATION
 
You are advised to read this Quarterly Report in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q, Annual Report on Form 10-K, and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov .
  
ITEM 3.  QU A NTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
Our business is currently conducted principally in the United States. As a result, our financial results are not affected by factors such as changes in foreign currency exchange rates or economic conditions in foreign markets. We do not engage in hedging transactions to reduce our exposure to changes in currency exchange rates, although as the geographical scope of our business broadens, we may do so in the future.
 
Our exposure to risk for changes in interest rates relates primarily to our investments in short-term financial instruments. Investments in both fixed rate and floating rate interest earning instruments carry some interest rate risk. The fair value of fixed rate securities may fall due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Partly as a result of this, our future interest income may fall short of expectations due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that have fallen in estimated fair value due to changes in interest rates. However, as substantially all of our cash equivalents consist of bank deposits and short-term money market instruments, we do not expect any material change with respect to our net income as a result of an interest rate change.
 
We do not hold any derivative instruments and do not engage in any hedging activities.
 
 
 
 
  ITEM 4.    CO N TROLS AND PROCEDURES
 
(a)              Evaluation of Disclosure Controls and Procedures
 
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures were designed to provide reasonable assurance that the controls and procedures would meet their objectives. As required by SEC Rule 13a-15(b), our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.
     
Our Chief Executive Officer and Chief Financial Officer are responsible for establishing and maintaining adequate internal control over our financial reporting. In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act, management has conducted an assessment, including testing, using the criteria in Internal Control — Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (“ COSO ”). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Management has used the framework set forth in the report entitled Internal Control-Integrated Framework published by the COSO to evaluate the effectiveness of our internal control over financial reporting. Based on this assessment, our Chief Executive Officer and Chief Financial Officer have concluded that our internal control over financial reporting was effective as of September 30, 2018. This Quarterly Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Our internal control over financial reporting was not subject to attestation by our independent registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this Quarterly Report. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.
 
(b)              Changes in Internal Controls Over Financial Reporting
 
There have been no changes in our internal controls over financial reporting or in other factors that could materially affect, or are reasonably likely to affect, our internal controls over financial reporting during the quarter ended September 30, 2018. There have not been any significant changes in the Company’s critical accounting policies identified since the Company filed its Annual Report on Form 10-K for the year ended December 31, 2017.
  
 
 
 
PA R T II
 
OTHER INFORMATION
 
ITEM 1.  LEGAL PROCEEDINGS
 
On December 31, 2014, various plaintiffs, individually and on behalf of a purported nationwide and sub-class of purchasers, filed a lawsuit in the U.S. District Court for the Northern District of California, captioned  Ryan et al. v. Gencor Nutrients, Inc. et al. , Case No.: 4:14-CV-05682. The lawsuit includes claims made against the manufacturer and various producers and sellers of products containing a nutritional supplement known as Testofen, which is manufactured and sold by Gencor Nutrients, Inc. (“ Gencor ”). Specifically, the Ryan plaintiffs allege that various defendants have manufactured, marketed and/or sold Testofen, or nutritional supplements containing Testofen, and in doing so represented to the public that Testofen had been clinically proven to increase free testosterone levels. According to the plaintiffs, those claims are false and/or not statistically proven. Plaintiffs seek relief under violations of the Racketeering Influenced Corrupt Organizations Act, breach of express and implied warranties, and violations of unfair trade practices in violation of California, Pennsylvania, and Arizona law. NDS utilizes Testofen in a limited number of nutritional supplements it manufactures and sells pursuant to a license agreement with Gencor.
 
On February 19, 2015 this matter was transferred to the Central District of California to the Honorable Manuel Real. Judge Real had previously issued an order dismissing a similar lawsuit that had been filed by the same lawyer who represents the plaintiffs in the Ryan matter. The United States Court of Appeals reversed part of the dismissal issued by Judge Real and remanded the case back down to the district court for further proceedings. As a result, the parties in the Ryan matter issued a joint status report and that matter is again active.
 
We are currently not involved in any litigation except as noted above that we believe could have a material adverse effect on our financial condition or results of operations. Other than described above, there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or any of its subsidiaries, threatened against or affecting the Company, our common stock, any of our subsidiaries or of the Company’s or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.
 
ITEM 1A.   RISK F A CTORS
 
Our results of operations and financial condition are subject to numerous risks and uncertainties described in our Annual Report on Form 10-K for our fiscal year ended December 31, 2017, filed on April 17, 2018. You should carefully consider these risk factors in conjunction with the other information contained in this Quarterly Report. Should any of these risks materialize, our business, financial condition and future prospects could be negatively impacted. As of September 30, 2018, there are no risk factors identified by the Company in addition to the risk factors previously disclosed in Part I, Item 1A, “ Risk Factors ” in our Annual Report on Form 10-K for the year ended December 31, 2017.
 
ITEM 2.   UNREGI S TERED SALES OF EQUITY SECURITIES
 
None.
 
ITEM   3.   DE F AULTS UPON SENIOR SECURITIES
 
There were no defaults upon senior securities during the three-month period ended September 30, 2018.
 
ITEM 5. OT H ER INFORMATION
 
Withdrawal of Series A Preferred, Series B Preferred and Series C Preferred
 
On November 13, 2018, the Company filed Certificates of Withdrawal with the Secretary of State of the State of Nevada for the Series A Preferred, Series B Preferred and Series C Preferred, thereby withdrawing each of the series of preferred stock and returning all previously designated shares to their status as authorized preferred stock available for issuance.
 
Creation of a New Series A Convertible Preferred Stock
 
On November 13, 2018, the Company filed a new Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock (the “ Certificate of Designations ”) with the Secretary of State of the State of Nevada, designating 1,000 shares of the Company’s preferred stock as Series A Convertible Preferred Stock, $0.01 par value (the “ New Series A Preferred ”). Shares of the New Series A Preferred have a stated value of $1,000 per share (“ Stated Value ”), subject to certain adjustments, and accrue dividends annually at a rate of 12%, which dividends compound monthly and shall be paid quarterly, at the Company’s election, in either cash or shall accrue and increase the Stated Value of the Series A Preferred. Shares of the New Series A Preferred rank senior to the Company’s common stock.
 
Each share of the New Series A Preferred has a liquidation preference equal to the Stated Value plus all accrued and unpaid dividends (the “ Liquidation Preference ”), and is convertible into that number of shares of the Company’s common stock equal to the Liquidation Preference divided by $0.46 (the “ Conversion Shares ”). Holders of New Series A Preferred may elect to convert shares of New Series A Preferred into Conversion Shares at any time. The Company, at its sole option, may choose to redeem all or a portion of New Series A Preferred at any time for 115% of the Liquidation Preference per share (the “ Redemption Price ”); provided, however , in the event of a Change of Control (as such term is defined in the Certificate of Designations), the Company shall be required to redeem all issued and outstanding shares of New Series A Preferred for the Redemption Price.
 
Holders of New Series A Preferred will have the right to vote, on an as-converted basis, with the holders of the Company’s common stock on any matter presented to the Company’s stockholders for their action or consideration. However, so long as any shares of New Series A Preferred remain outstanding, holders of the Series A Preferred will have the right to elect one director to the Company’s Board of Directors (“ Board ”) (the “ Series A Director ”); provided, however , so long as Dayton Judd remains on the Company’s Board, he shall be deemed to be the Series A Director. Furthermore, so long as any shares of New Series A Preferred remain outstanding, the Company may not, without the affirmative vote or consent of at least 50% of the shares of issued and outstanding New Series A Preferred on such date, voting as a separate class, (i) authorize, create, issue or alter any class of debt or equity securities ranking pari passu or senior to the New Series A Preferred; (ii) amend provisions of the New Series A Preferred; (iii) repurchase, redeem or pay dividends on any class of junior securities, subject to certain exceptions; (iv) amend the Company’s Articles of Incorporation or Bylaws in any way that will have a material adverse effect on the rights of the New Series A Preferred; (v) after February 16, 2019, increase the size of the Board to more than five members; (vi) take any action that would constitute a Fundamental Transaction (as such term is defined in the Certificate of Designations); or (vii) incur any additional indebtedness other than through the Company’s Merchant Agreement, any other line of credit with Compass or under any similar replacement facility.
 
In addition, holders of the New Series A Preferred shall have certain piggyback registration rights for the first two years following November 13, 2018, and certain demand registration rights thereafter, as more specifically set forth in the Certificate of Designations.
 
New Series A Preferred Financing
 
On November 13, 2018, the Company entered into subscription agreements (the “ Subscription Agreements ”) with certain accredited investors (each, a “Purchaser ” and together, the “ Purchasers ”), pursuant to which the Company offered and sold to the Purchasers an aggregate of 600 units (“ Units ”) for $1,000 per Unit, with each Unit consisting of one share of New Series A Preferred and warrant to purchase that number of shares of Company common stock equal to 30% of the shares of Company common stock issuable upon conversion of the New Series A Preferred purchased by the Purchaser (“ Warrant ”) (the “ Offering ”). The Warrants shall expire five years from the date of issuance, and are exercisable at a price of $0.46 per share. Warrants to purchase an aggregate of 391,304 shares of Company common stock were issued in the Offering.
 
The Offering resulted in gross proceeds to the Company of $600,000. Purchasers in the Offering included Dayton Judd, the Company’s Chairman and Chief Executive Officer, and Grant Dawson, a director. A portion of the offering was also sold to an unaffiliated third party.
 
The issuance of the shares of New Series A Preferred and Warrants issued as a part of the Units were exempt from the registration requirements of the Securities Act of 1933, as amended (the “ Securities Act ”), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as provided in Rule 506 of Regulation D promulgated thereunder. The shares of New Series A Preferred, Warrants and the shares of Company common stock issuable upon exercise of the Warrants have not been registered under the Securities Act or any other applicable securities laws, and unless so registered, may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act.
 
 
 
 
  ITEM 6.  EX H IBITS
 
 
Certificates of Withdrawal of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, and Series C Convertible Preferred Stock, dated November 13, 2018
 
Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock, dated November 13, 2018
 
Form of Warrant, dated November 13, 2018
 
Form of Subscription Agreemen t
 
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act.
 
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act.
 
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act.
 
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act.
101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase
101.LAB
 
XBRL Taxonomy Extension Label Linkbase
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase
 
 
 
 
 
 
 
SIG N ATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Registrant
 
Date: November 14, 2018
FitLife Brands, Inc.
 
By: /s/ Dayton Judd
 
 
Dayton Judd
 
Chief Executive Officer and Director
(Principal Executive Officer)
 
 
Registrant
 
Date: November 14, 2018
FitLife Brands, Inc.
 
By: /s/ Michael Abrams
 
 
Michael Abrams
 
Chief Financial Officer and Director
(Principal Financial Officer)
 
 
 
 
-20-
 
Exhibit 3.1
 
 
 
 
 
 
 
 
Exhibit 3.2
 
CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF
SERIES A CONVERTIBLE PREFERRED STOCK
OF
FITLIFE BRANDS, INC.
 
The undersigned, the Chief Financial Officer of FitLife Brands, Inc., a Nevada corporation (the “ Company ”), in accordance with the provisions of Section 78.195 of the Nevada Revised Statutes, does hereby certify that, pursuant to the authority conferred upon the Board of Directors of the Company by the Articles of Incorporation of the Company, the following resolution creating a series of Series A Convertible Preferred Stock, was duly adopted on November 9, 2018:
 
RESOLVED, that pursuant to the authority expressly granted to and vested in the Board of Directors of the Company by provisions of the Articles of Incorporation of the Company, as amended (the “ Articles of Incorporation ”), there hereby is created out of the shares of preferred stock, par value $0.01 per share, of the Company authorized in Article III of the Articles of Incorporation (the “ Preferred Stock ”), a series of Preferred Stock of the Company, to be named “Series A Convertible Preferred Stock,” consisting of One Thousand (1,000) shares, which series shall have the following designations, powers, preferences and relative and other special rights and the following qualifications, limitations and restrictions:
 
TERMS OF SERIES A PREFERRED STOCK
 
1.            Designation and Rank . The designation of such series of the Preferred Stock shall be the Series A Convertible Preferred Stock, par value $0.01 per share (the “ Series A Preferred ”).   The maximum number of shares of Series A Preferred shall be One Thousand (1,000) shares. The Series A Preferred shall rank senior to the Company’s common stock, par value $0.01 per share (the “ Common Stock ”),   and to all other classes and series of equity securities of the Company that by their terms do not rank senior to the Series A Preferred (“ Junior Stock ”). Each share of Series A Preferred shall have a stated value equal to One Thousand Dollars ($1,000) (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization affecting such shares, or in the event of the payment of any Capitalized Dividends, as defined in Section 2(a) below) (the “ Stated Value ”).
 
2.            Dividends .
 
(a)   Payment of Dividends .  The holders of record of shares of Series A Preferred shall be entitled to receive, out of any assets at the time legally available therefor, cumulative dividends at the rate of twelve percent (12%) of the stated Liquidation Preference Amount (as defined in Section 4 hereof) per share per annum commencing on November 13, 2018 (the “ Issuance Date ”), compounded monthly and payable quarterly on or before ten (10) business days after the end of each applicable quarter following the Issuance Date (each, a “ Dividend Payment Date ”), and shall, at the Company’s election, be paid in cash or shall accrue and increase the Stated Value of such Series A Preferred (“ Capitalized Dividends ”); provided, however, that in the event that the dividends on the Series A Preferred are not paid in cash on or before the applicable Dividend Payment Date, such dividends shall constitute Capitalized Dividends and shall automatically accrue and increase the Stated Value of such Series A Preferred; provided, further , notwithstanding the foregoing, the Company shall pay all dividends accrued after May 13, 2020 in cash (“ Cash Dividend Payment Date ”). On or after the Cash Dividend Payment Date, such dividends shall accrue on each share of Series A Preferred from day to day whether or not earned or declared. Such accrued but unpaid dividends on or after the Cash Dividend Payment Date shall be fully paid on, or declared and set apart for, such shares of Series A Preferred before any distribution shall be paid on, or declared and set apart for Junior Stock.
 
(b) So long as any shares of Series A Preferred are issued and outstanding, the Company shall not declare, pay or set apart for payment any dividend or make any distribution on any Junior Stock.
 
 
 
-1-
 
 
(c) In the event of a dissolution, liquidation or winding up of the Company pursuant to Section 4 after the Cash Dividend Payment Date, all accrued and unpaid dividends on the Series A Preferred shall be payable on the day immediately preceding the date of payment of the preferential amount to the holders of Series A Preferred. In the event of a redemption upon the occurrence of a Change of Control (as defined in Section 8(b)) after the Cash Dividend Payment Date, all accrued and unpaid dividends on the Series A Preferred shall be payable on the day immediately preceding the date of such redemption.
 
(d) For purposes hereof, unless the context otherwise requires, “distribution” shall mean the transfer of cash or property without consideration, whether by way of dividend or otherwise, payable other than in shares of Common Stock or other equity securities of the Company, or the purchase or redemption of shares of the Company (other than redemptions set forth in Section 8 below or repurchases of Common Stock held by employees or consultants of the Company upon termination of their employment or services pursuant to agreements providing for such repurchase or upon the cashless exercise of options held by employees or consultants) for cash or property.
 
3.            Voting Rights .
 
(a) General Voting Rights . On any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders of the Company (or by written consent of stockholders in lieu of meeting), each holder of outstanding shares of Series A Preferred shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series A Preferred held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter, or if no record date is established, at the date such vote is taken or any written consent of stockholders is solicited. Except as provided by law or by Section 3(b) or (c) below, holders of Series A Preferred shall vote together with the holders of Common Stock, and with the holders of any other series of Preferred Stock the terms of which so provide, as a single class.
 
(b) Election of Directors .
 
(i) So long  as any shares of the Series A Preferred remain outstanding, the holders of a majority of the outstanding shares of the Series A Preferred shall be entitled to appoint one member to the Company’s Board of Directors (the “ Board ”) by written notice to the Company designating a person to serve as a director (the “ Series A Director ”); provided, however , so long as Dayton Judd remains a director on the Board, he shall be deemed to be the Series A Director, and holders of the Series A Preferred shall not have the option to designate any other individual as the Series A Director. A Series A Director may only be removed or replaced by vote or written consent of holders of a majority of the Series A Preferred.
 
(ii) At any meeting held for the purpose of electing the Series A Director, the presence in person or by proxy of the holders of a majority of the shares of Series A Preferred then outstanding shall constitute a quorum of the Series A Preferred for the purpose of electing directors by holders of the Series A Preferred. A vacancy in any directorship filled by the holders of Series A Preferred shall be filled only by vote or written consent in lieu of a meeting of the holders of a majority of the Series A Preferred or pending any vote or written consent of the holders of the Series A Preferred.
 
(iii) Commencing February 16, 2019, so long as any shares of the Series A Preferred remain outstanding, the Company’s Board shall not consist of more than five (5) members.
 
 
 
-2-
 
 
(c) Class Voting Rights . The Series A Preferred shall have the following class voting rights. So long as any shares of the Series A Preferred remain outstanding, the Company shall not, without the affirmative vote or consent of the holders of at least fifty percent (50%) of the shares of the Series A Preferred issued and outstanding on such date given in person or by proxy, either in writing or at a meeting, in which the holders of the Series A Preferred vote separately as a class: (i) authorize, create, issue or increase the authorized or issued amount of any class of debt or equity securities, ranking pari passu or senior to the Series A Preferred, with respect to the distribution of assets on liquidation, dissolution or winding up; (ii) amend, alter or repeal the provisions of the Series A Preferred, whether by merger, consolidation or otherwise, so as to adversely affect any right, preference, privilege or voting power of the Series A Preferred;  provided, however , that any creation and issuance of another series of Junior Stock shall not be deemed to adversely affect such rights, preferences, privileges or voting powers; (iii) repurchase, redeem or pay dividends on, shares of Common Stock or any other shares of the Company’s Junior Stock (other than (1) in connection with any employee stock option plan or employee stock purchase plan which is approved by the Board and is existing as of the date hereof, (2) de minimus repurchases from employees of the Company, and (3) any contractual redemption obligations existing as of the date hereof as disclosed in the Company’s public filings with the Securities and Exchange Commission (“ SEC ”)); (iv) amend the Company’s Articles of Incorporation or bylaws so as to affect materially and adversely any right, preference, privilege or voting power of the Series A Preferred;  provided, however, that any creation and issuance of another series of Junior Stock shall not be deemed to adversely affect such rights, preferences, privileges or voting powers; (v) subsequent to February 16, 2019, increase the number of members that make up the Board to more than five (5) members; (vi) subject to the Company’s fiduciary duties under Nevada law, take any action that would constitute a Fundamental Transaction (as defined hereafter); or (vii) incur any indebtedness for borrowed money or issue any debt securities, or assume, guarantee or endorse, or otherwise as an accommodation become responsible for, the obligations of any person for borrowed money; provided, however , notwithstanding the foregoing, nothing contained herein shall prevent or prohibit the Company or any of its subsidiaries from incurring indebtedness for borrowed money or otherwise incurring any obligations under the Company’s Merchant Agreement or other line of credit agreement with Compass Bank (the “ Facility ”) and/or any replacement Facility. For purposes of this Section, a “Fundamental Transaction” shall occur if: (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another person, (ii) the Company, directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another person whereby such other person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other person or other persons making or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement or other business combination).
 
 
 
-3-
 
 
4.             Liquidation, Dissolution; Winding-Up .
 
(a) In the event of the liquidation, dissolution or winding up of the affairs of the Company, whether voluntary or involuntary, the holders of shares of the Series A Preferred then outstanding shall be entitled to receive, out of the assets of the Company available for distribution to its stockholders, an amount equal to the Stated Value plus all accrued and unpaid dividends (the “ Liquidation Preference Amount ”) before any payment shall be made or any assets distributed to the holders of the Common Stock or any other Junior Stock. If the assets of the Company are not sufficient to pay in full the Liquidation Preference Amount payable to the holders of outstanding shares of the Series A Preferred and any series of preferred stock or any other class of stock on a parity, as to rights on liquidation, dissolution or winding up, with the Series A Preferred, then all of said assets will be distributed among the holders of the Series A Preferred and the other classes of stock on a parity with the Series A Preferred, if any, ratably in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. The liquidation payment with respect to each outstanding fractional share of Series A Preferred shall be equal to a ratably proportionate amount of the liquidation payment with respect to each outstanding share of Series A Preferred. All payments for which this Section 4(a) provides shall be in cash, property (valued at its fair market value as determined reasonably and in good faith by the Board) or a combination thereof; provided, however, that no cash shall be paid to holders of Junior Stock unless each holder of the outstanding shares of Series A Preferred has been paid in cash the full Liquidation Preference Amount to which such holder is entitled as provided herein. After payment of the full Liquidation Preference Amount to which each holder is entitled, such holders of shares of Series A Preferred will not be entitled to any further participation as such in any distribution of the assets of the Company.
 
(b) Written notice of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, stating a payment date and the place where the distributable amounts shall be payable, shall, to the extent possible, be given by mail, postage prepaid, no less than twenty (20) business days prior to the payment date stated therein, to the holders of record of the Series A Preferred at their respective addresses as the same shall appear on the books of the Company.
 
5.             Conversion . The holder of Series A Preferred shall have the following conversion rights (the “ Conversion Rights ”):
 
(a)  Voluntary Conversion . At any time on or after the Issuance Date, the holder of any shares of Series A Preferred may, at such holder’s option, elect to convert (a “ Voluntary Conversion ”) all or any portion of the shares of Series A Preferred held by such person into a number of fully paid and nonassessable shares of Common Stock equal to the quotient of (i) the Liquidation Preference Amount of the shares of Series A Preferred being converted divided by (ii) the Conversion Price (as defined in Section 5(d) below) then in effect as of the date of the delivery by such holder of its notice of election to convert (the “ Conversion Shares ”). In the event of a notice of redemption of any shares of Series A Preferred pursuant to Section 8 hereof, the Conversion Rights of the shares of Series A Preferred designated for redemption shall terminate at the close of business on the last full day preceding the date fixed for redemption, unless the redemption price is not paid on such redemption date, in which case the Conversion Rights for such shares shall continue until such price is paid in full. In the event of a liquidation, dissolution or winding up of the Company, the Conversion Rights shall terminate at the close of business on the last full day preceding the date fixed for the payment of any such amounts distributable on such event to the holders of Series A Preferred. In the event of such a redemption or liquidation, dissolution or winding up, the Company shall provide to each holder of shares of Series A Preferred notice of such redemption or liquidation, dissolution or winding up, which notice shall (i) be sent at least fifteen (15) business days prior to the termination of the Conversion Rights, and (ii) state the amount per share of Series A Preferred that will be paid or distributed on such redemption or liquidation, dissolution or winding up, as the case may be.
 
 
-4-
 
 
 
(b)   Mandatory Conversion . If, at any time, (i) the Conversion Shares are registered pursuant to Section 12(b) or (g) under the Securities Exchange Act of 1934, as amended. (ii) there are sufficient authorized but unissued shares (which have not otherwise been reserved or committed for issuance) to permit the issuance of Conversion Shares. (iii) upon issuance, the Conversion Shares will be either (A) covered by an effective registration statement under the Securities Act of 1933, as amended (“ Securities Act ”), which is then available for the immediate resale of such Conversion Shares by the recipients thereof, and the Board reasonably believes that such effectiveness will continue uninterrupted for the foreseeable future, or (B) freely tradable without restriction pursuant to Rule 144 promulgated under the Securities Act, as determined by counsel to the Company as set forth in a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected holders. and (iv) the VWAP of the Common Stock is at least $1.25 per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization affecting such shares) for thirty (30) consecutive trading days, then the Company shall have the right, subject to the terms and conditions of this Section 5, to convert all of the issued and outstanding shares of Series A Preferred into Conversion Shares.
 
For purposes of this Section 5, " VWAP " means , for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock then listed or quoted on a trading market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the trading market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York time) to 4:02 p.m. (New York City time)) , (b) if OTCQB or OTCQX is not a trading market, the volume weighted average price of a share of Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX as applicable, (c) if Common Stock is not then listed or quoted for trading on the OTCQB or OTCQX and if prices for Common Stock are then reported on the OTC Pink Open Market published by OTC Markets Group , Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported , or (d) in all other cases, the fair market value of the Common Stock as determined by an independent appraiser selected in good faith by the holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.
 
(c)  Mechanics of Conversion . Conversions of Series A Preferred shall be conducted in the following manner:
 
(i)   Voluntary Conversion . To convert Series A Preferred into Conversion Shares on any date (the “ Voluntary Conversion Date ”), the holder thereof shall transmit by facsimile (or otherwise deliver), for receipt on or prior to 5:00 p.m., New York time on such date, a copy of a fully executed notice of conversion in the form attached hereto as Exhibit A (the “ Conversion Notice ”), to the Company. As soon as practicable following such Voluntary Conversion Date, unless such shares of Series A Preferred are held in book-entry form, the holder shall surrender to a common carrier for delivery to the Company the original certificates representing the shares of Series A Preferred being converted (or an indemnification undertaking with respect to such shares in the case of their loss, theft or destruction) (the “ Preferred Stock Certificates ”) and the originally executed Conversion Notice.
 
(ii)               Mandatory Conversion . In the event the Company elects to convert outstanding shares of Series A Preferred into Conversion Shares in pursuant to Section 5(b) above, the Company shall give written notice (the “ Mandatory Conversion Notice ”) to all holders of the Series A Preferred of its intention to require the conversion of the Series A Preferred identified therein. The Mandatory Conversion Notice shall set forth the number of Series A Preferred being converted, the date on which such conversion shall be effective (the “ Mandatory Conversion Date ”), and shall be given to the holders of the Series A Preferred not less than ten (10) business days prior to the Mandatory Conversion Date. The Mandatory Conversion Notice shall be delivered to each holder at the address as it appears on the stock transfer books of the Company. In order to receive the Conversion Shares into which the Series A Preferred is convertible pursuant to Section 5(b), if such shares of Series A Preferred were not issued in book entry form on the books and records of the Company, each holder of the Series A Preferred shall surrender to the Company at the place designated in the Mandatory Conversion Notice the certificates(s) representing the number of shares of Series A Preferred specified in the Mandatory Conversion Notice. Upon the Mandatory Conversion Date, such converted Series A Preferred shall no longer be deemed to be outstanding, and all rights of the holder with respect to such shares shall immediately terminate, except the right to receive the shares of Common Stock into which the Series C Preferred is convertible pursuant to Section 5(b).  
 
 
 
-5-
 
 
(iii)  Company’s Response . Upon receipt by the Company of a copy of the fully executed Conversion Notice, the Company or its designated transfer agent (the “ Transfer Agent ”), as applicable, shall within three (3) business days following the date of receipt by the Company of a copy of the fully executed Conversion Notice (the “ Share Delivery Date ”), issue and deliver to the Depository Trust Company (“ DTC ”) account on the holder’s behalf via the Deposit Withdrawal Agent Commission System (“ DWAC ”) as specified in the Conversion Notice, registered in the name of the holder or its designee, for the number of Conversion Shares which the holder shall be entitled. Notwithstanding the foregoing to the contrary, the Company or the Transfer Agent shall only be required to issue and deliver the Conversion Shares to the DTC on a holder’s behalf via DWAC if (i) such conversion is in connection with a sale, (ii) the shares of Common Stock may be issued without restrictive legends, and (iii) the Company and the Transfer Agent are participating in DTC through the DWAC system. If all of the conditions set forth in clauses (i), (ii) and (iii) above are not satisfied, the Company shall deliver physical certificates to the holder or its designee. If the number of shares of Series A Preferred held by the holder submitted for conversion is greater than the number of shares of Series A Preferred being converted, then the Company shall, in the event such shares are represented by a stock certificate (“ Preferred Stock Certificate ”), as soon as practicable and in no event later than three (3) business days after receipt of the Preferred Stock Certificate(s) and at the Company’s expense, issue and deliver to the holder a new Preferred Stock Certificate representing the number of shares of Series A Preferred not converted. In the event the shares of Series A Preferred held by the holder are represented in book entry form on the books and records of the Company, the shares of Series A Preferred shall be cancelled on the books and records of the Company effective on the Share Delivery Date.
 
 (iv)  Dispute Resolution . In the case of a dispute as to the arithmetic calculation of the number of Conversion Shares to be issued upon conversion, the Company shall cause its Transfer Agent to promptly issue to the holder the number of Conversion Shares that is not disputed and shall submit the arithmetic calculations to the holder via facsimile as soon as possible, but in no event later than two (2) business days after receipt of such holder’s Conversion Notice. If such holder and the Company are unable to agree upon the arithmetic calculation of the number of Conversion Shares to be issued upon such conversion within two (2) business days of such disputed arithmetic calculation being submitted to the holder, then the Company shall within two (2) business days submit via facsimile the disputed arithmetic calculation of the number of Conversion Shares to be issued upon such conversion to the Company’s independent, outside accountant (the “ Accountant ”). The Company shall cause the Accountant to perform the calculations and notify the Company and the holder of the results no later than five (5) business days from the time it receives the disputed calculations. The Accountant’s calculation shall be binding upon all parties absent manifest error. The reasonable expenses of such Accountant in making such determination shall be paid by the Company, in the event the holder’s calculation was correct, or by the holder, in the event the Company’s calculation was correct, or equally by the Company and the holder in the event that neither the Company’s or the holder’s calculation was correct. The period of time in which the Company is required to effect conversions or redemptions under this Certificate of Designations shall be tolled with respect to the subject conversion or redemption pending resolution of any dispute by the Company made in good faith and in accordance with this Section 5(b)(iii).
 
(v)  Record Holder . The person or persons entitled to receive the Conversion Shares shall be treated for all purposes as the record holder or holders of such Conversion Shares on the Conversion Date.
 
(vi)  Company’s Failure to Deliver Conversion Shares .  If, in the case of any Conversion Notice, such Conversion Shares are not delivered to or as directed by the applicable holder by the Share Delivery Date, in addition to any other rights herein, the holder shall be entitled to elect by written notice to the Company at any time on or before its receipt of such Conversion Shares, to rescind such Voluntary Conversion, in which event the Company shall promptly return to the holder any original Series A Preferred Stock Certificate delivered to the Company and the holder shall promptly return to the Company the Conversion Shares issued to such holder pursuant to the rescinded Conversion Notice.
 
 
 
-6-
 
 
(vii)   Partial Liquidated Damages . If the Company fails to deliver to a holder such Conversion Shares pursuant to Section 5(b)(ii) on the Share Delivery Date applicable to such conversion, the Company shall pay to such holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Stated Value of the Series A Preferred being converted, $10.00 per business day (increasing to $20.00 per business day on the fifth (5 th ) business day after such damages begin to accrue) for each business day after the Share Delivery Date until such Conversion Shares are delivered or the holder rescinds such conversion. Nothing herein shall limit a holder’s right to pursue actual damages for the Company’s failure to deliver Conversion Shares within the period specified herein and such holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit a holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.
 
(viii)  Buy-In Rights   In addition to any other rights available to the holders of Series A Preferred, if within three (3) business days of the Company’s receipt of an executed copy of the Conversion Notice (so long as the applicable Preferred Stock Certificates and original Conversion Notice are received by the Company on or before such third (3 rd ) business day), the Transfer Agent shall fail to issue and deliver to a holder the number of shares of Common Stock to which such holder is entitled upon such holder’s conversion of the Series A Preferred (a “ Conversion Failure ”), and if after such date the holder is required by its broker to purchase (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the holder of the shares of Common Stock issuable upon conversion of Series A Preferred which the holder anticipated receiving upon such conversion (a “ Buy-In ”), then the Company shall, within three (3) business days after such Conversion Failure, (1) pay in cash to the holder the amount by which (x) the holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (A) the number of shares of Common Stock issuable upon conversion of Series A Preferred that the Company was required to deliver to the holder in connection with the conversion at issue times (B) the price at which the sell order giving rise to such purchase obligation was executed, and (2) deliver to the holder the number of shares of Common Stock that would have been issued had the Company timely complied with its conversion and delivery obligations hereunder. For example, if the holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (1) of the immediately preceding sentence the Company shall be required to pay to the holder $1,000. The holder shall provide the Company written notice indicating the amounts payable to the holder in respect of the Buy-In, together with applicable confirmations and other evidence reasonably requested by the Company. Nothing herein shall limit a holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock upon conversion of the Series A Preferred as required pursuant to the terms hereof.
 
(d)  Conversion Price . The term “Conversion Price” shall mean $0.46, subject to adjustment under Section 5(e) hereof.
 
(e)  Adjustments of Conversion Price .
 
(i)  Adjustments for Stock Splits and Combinations . If the Company shall at any time or from time to time after the Issuance Date, effect a stock split of the outstanding Common Stock, the Conversion Price shall be proportionately decreased. If the Company shall at any time or from time to time after the Issuance Date, combine the outstanding shares of Common Stock, the Conversion Price shall be proportionately increased. Any adjustments under this Section 5(e)(i) shall be effective at the close of business on the date the stock split or combination becomes effective.
 
 (ii)  Adjustments for Certain Dividends and Distributions . If the Company shall at any time or from time to time after the Issuance Date, make or issue or set a record date for the determination of holders of Common Stock entitled to receive a dividend or other distribution payable in shares of Common Stock, then, and in each event, the Conversion Price shall be decreased as of the time of such issuance or, in the event such record date shall have been fixed, as of the close of business on such record date, by multiplying the Conversion Price then in effect by a fraction:
 
 
 
-7-
 
 
(1) the numerator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date; and
 
(2) the denominator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such dividend or distribution; provided, however, that no such adjustment shall be made if the holders of Series A Preferred simultaneously receive (i) a dividend or other distribution of shares of Common Stock in a number equal to the number of shares of Common Stock as they would have received if all outstanding shares of Series A Preferred had been converted into Common Stock on the date of such event, or (ii) a dividend or other distribution of shares of Series A Preferred which are convertible, as of the date of such event, into such number of shares of Common Stock as is equal to the number of additional shares of Common Stock being issued with respect to each share of Common Stock in such dividend or distribution.
 
(iii)  Adjustment for Other Dividends and Distributions . If the Company shall at any time or from time to time after the Issuance Date, make or issue or set a record date for the determination of holders of Common Stock entitled to receive a dividend or other distribution payable in securities of the Company other than shares of Common Stock, then, and in each event, an appropriate revision to the applicable Conversion Price shall be made and provision shall be made (by adjustments of the Conversion Price or otherwise) so that the holders of Series A Preferred shall receive upon conversions thereof, in addition to the number of shares of Common Stock receivable thereon, the number of securities of the Company which they would have received had their Series A Preferred been converted into Common Stock on the date of such event and had thereafter, during the period from the date of such event to and including the Conversion Date, retained such securities (together with any distributions payable thereon during such period), giving application to all adjustments called for during such period under this Section 5(e)(iii) with respect to the rights of the holders of the Series A Preferred; provided, however , that if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed therefor, the Conversion Price shall be adjusted pursuant to this paragraph as of the time of actual payment of such dividends or distributions.
 
(iv)  Adjustments for Reclassification, Exchange or Substitution . If the Common Stock issuable upon conversion of the Series A Preferred Stock at any time or from time to time after the Issuance Date shall be changed to the same or different number of shares of any class or classes of stock, whether by reclassification, exchange, substitution or otherwise (other than by way of a stock split or combination of shares or stock dividends provided for in Sections 5(e)(i), (ii) and (iii), or a reorganization, merger, consolidation, or sale of assets provided for in Section 5(e)(v)), then, and in each event, an appropriate revision to the Conversion Price shall be made and provisions shall be made (by adjustments of the Conversion Price or otherwise) so that the holder of each share of Series A Preferred shall have the right thereafter to convert such share of Series A Preferred into the kind and amount of shares of stock and other securities receivable upon reclassification, exchange, substitution or other change, by holders of the number of shares of Conversion Shares into which such share of Series A Preferred might have been converted immediately prior to such reclassification, exchange, substitution or other change, all subject to further adjustment as provided herein.
 
 
 
-8-
 
 
 (v)  Adjustments for Reorganization, Merger, Consolidation or Sales of Assets . If at any time or from time to time after the Issuance Date there shall be a capital reorganization of the Company (other than by way of a stock split or combination of shares or stock dividends or distributions provided for in Section 5(e)(i), (ii) and (iii), or a reclassification, exchange or substitution of shares provided for in Section 5(e)(iv)), or a merger or consolidation of the Company with or into another corporation where the holders of outstanding voting securities prior to such merger or consolidation do not own over 50% of the outstanding voting securities of the merged or consolidated entity, immediately after such merger or consolidation, or the sale of all or substantially all of the Company’s properties or assets to any other person (an “ Organic Change ”), then as a part of such Organic Change an appropriate revision to the Conversion Price shall be made if necessary and provision shall be made if necessary (by adjustments of the Conversion Price or otherwise) so that the holder of each share of Series A Preferred shall have the right thereafter to convert such share of Series A Preferred into the kind and amount of shares of stock and other securities or property which such holder would have had the right to receive had such holder converted its shares of Series A Preferred immediately prior to the consummation of such Organic Change. In any such case, appropriate adjustment shall be made in the application of the provisions of this Section 5(e)(v) with respect to the rights of the holders of the Series A Preferred after the Organic Change to the end that the provisions of this Section 5(e)(v) (including any adjustment in the Conversion Price then in effect and the number of shares of stock or other securities deliverable upon conversion of the Series A Preferred) shall be applied after that event in as nearly an equivalent manner as may be practicable.
 
(vi)  Record Date . In case the Company shall take record of the holders of its Common Stock or any other Preferred Stock for the purpose of entitling them to subscribe for or purchase Common Stock or Convertible Securities, then the date of the issue or sale of the shares of Common Stock shall be deemed to be such record date.
  
(f)  No Impairment . The Company shall not, by amendment of its Articles of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith, assist in the carrying out of all the provisions of this Section 5 and in the taking of all such action as may be necessary or appropriate in order to protect the Conversion Rights of the holders of the Series A Preferred against impairment. In the event a holder shall elect to convert any shares of Series A Preferred as provided herein, the Company cannot refuse conversion based on any claim that such holder or any one associated or affiliated with such holder has been engaged in any violation of law, unless (i) an order from the SEC prohibiting such conversion, or (ii) an injunction from a court, on notice, restraining and/or adjoining conversion of all or of said shares of Series A Preferred shall have been issued and the Company posts a surety bond for the benefit of such holder in an amount equal to 100% of the Liquidation Preference Amount of the Series A Preferred such holder has elected to convert, which bond shall remain in effect until the completion of arbitration/litigation of the dispute and the proceeds of which shall be payable to such holder in the event it obtains judgment. If the Company is the prevailing party in any legal action or other legal proceeding relating to the Conversion Rights of the holders of the Series A Preferred, then the Company shall be entitled to recover from the holders of Series A Preferred reasonable attorneys’ fees, costs and disbursements (in addition to any other relief to which the Company may be entitled).
 
(g)  Certificates as to Adjustments . Upon occurrence of each adjustment or readjustment of the Conversion Price or number of Conversion Shares issuable upon conversion of the Series A Preferred pursuant to this Section 5, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to each holder of such Series A Preferred a certificate setting forth such adjustment and readjustment, showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon written request of the holder of such affected Series A Preferred, at any time, furnish or cause to be furnished to such holder a like certificate setting forth such adjustments and readjustments, the Conversion Price in effect at the time, and the number of Conversion Shares and the amount, if any, of other securities or property which at the time would be received upon the conversion of a share of such Series A Preferred. Notwithstanding the foregoing, the Company shall not be obligated to deliver a certificate unless such certificate would reflect an increase or decrease of at least one percent of such adjusted amount.
 
 
 
-9-
 
 
(h)  Issue Taxes . The Company shall pay any and all issue and other taxes, excluding federal, state or local income taxes, that may be payable in respect of any issue or delivery of shares of Common Stock on conversion of shares of Series A Preferred pursuant thereto; provided, however, that the Company shall not be obligated to pay any transfer taxes resulting from any transfer requested by any holder in connection with any such conversion.
 
(i)  Notices . All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally or by facsimile or three (3) business days following being mailed by certified or registered mail, postage prepaid, return-receipt requested, addressed to the holder of record at its address appearing on the books of the Company. The Company will give written notice to each holder of Series A Preferred at least twenty (20) business days prior to the date on which the Company closes its books or takes a record (I) with respect to any dividend or distribution upon the Common Stock, (II) with respect to any pro rata subscription offer to holders of Common Stock, or (III) for determining rights to vote with respect to any Fundamental Transaction, Organic Change, dissolution, liquidation or winding-up and in no event shall such notice be provided to such holder prior to such information being made known to the public. The Company will also give written notice to each holder of Series A Preferred at least twenty (20) business days prior to the date on which any Fundamental Transaction, Organic Change, dissolution, liquidation or winding-up will take place and in no event shall such notice be provided to such holder prior to such information being made known to the public.
 
(j)  Fractional Shares . No fractional shares of Common Stock shall be issued upon conversion of the Series A Preferred. In lieu of any fractional shares to which the holder would otherwise be entitled, the Company shall pay cash equal to the product of such fraction multiplied by the Conversion Price.
 
(k)  Reservation of Common Stock . The Company shall, so long as any shares of Series A Preferred are outstanding, reserve and keep available out of its authorized and unissued Common Stock, solely for the purpose of effecting the conversion of the Series A Preferred, such number of shares of Common Stock as shall from time to time be sufficient to effect the conversion of all of the Series A Preferred then outstanding; provided that the number of shares of Common Stock so reserved shall at no time be less than 100% of the number of shares of Conversion Shares for which the shares of Series A Preferred are at any time convertible. The initial number of shares of Common Stock reserved for conversions of the Series A Preferred and each increase in the number of shares so reserved shall be allocated pro rata among the holders of the Series A Preferred based on the number of shares of Series A Preferred held by each holder of record at the time of issuance of the Series A Preferred or increase in the number of reserved shares, as the case may be. In the event a holder shall sell or otherwise transfer any of such holder’s shares of Series A Preferred, each transferee shall be allocated a pro rata portion of the number of reserved shares of Common Stock reserved for such transferor. Any shares of Common Stock reserved and which remain allocated to any person or entity which does not hold any shares of Series A Preferred shall be allocated to the remaining holders of Series A Preferred, pro rata based on the number of shares of Series A Preferred then held by such holder.
 
(l)  Retirement of Series A Preferred . Conversion of Series A Preferred shall be deemed to have been effected on the applicable Conversion Date. Upon conversion of only a portion of the number of shares of Series A Preferred represented by a certificate surrendered for conversion, the Company shall issue and deliver to such holder at the expense of the Company, a new certificate covering the number of shares of Series A Preferred representing the unconverted portion of the certificate so surrendered as required by Section 5(b)(ii).
 
(m)  Regulatory Compliance . If any shares of Common Stock to be reserved for the purpose of conversion of Series A Preferred require registration or listing with or approval of any governmental authority, stock exchange or other regulatory body under any federal or state law or regulation or otherwise before such shares may be validly issued or delivered upon conversion, the Company shall, at its sole cost and expense, in good faith and as expeditiously as possible, endeavor to secure such registration, listing or approval, as the case may be.
 
 
 
-10-
 
 
6.             No Preemptive Rights . Except as provided in Section 5 hereof, no holder of the Series A Preferred shall be entitled to rights to subscribe for, purchase or receive any part of any new or additional shares of any class, whether now or hereinafter authorized, or of bonds or debentures, or other evidences of indebtedness convertible into or exchangeable for shares of any class, but all such new or additional shares of any class, or any bond, debentures or other evidences of indebtedness convertible into or exchangeable for shares, may be issued and disposed of by the Board on such terms and for such consideration (to the extent permitted by law), and to such person or persons as the Board in their absolute discretion may deem advisable.
 
7.             Inability to Fully Convert .
 
(a)  Holder’s Option if Company Cannot Fully Convert . If, upon the Company’s receipt of a Conversion Notice, the Company cannot issue shares of Common Stock registered for resale under a registration statement for any reason (unless such registration statement is not then required to be effective), including, without limitation, because the Company (x) does not have a sufficient number of shares of Common Stock authorized and available, or (y) is otherwise prohibited by applicable law or by the rules or regulations of any stock exchange, interdealer quotation system or other self-regulatory organization with jurisdiction over the Company or its securities from issuing all of the Common Stock which is to be issued to a holder of Series A Preferred pursuant to a Conversion Notice, then the Company shall issue as many shares of Common Stock as it is able to issue in accordance with such holder’s Conversion Notice and pursuant to Section 5(c)(ii) above and, with respect to the unconverted Series A Preferred, the holder, solely at such holder’s option, can elect, within five (5) business days after receipt of notice from the Company thereof to:
 
(i) if the Company’s inability to fully convert Series A Preferred is pursuant to Section 7(a)(y) above, require the Company to issue restricted shares of Common Stock in accordance with such holder’s Conversion Notice and pursuant to Section 5(c)(ii) above;
 
(ii) void its Conversion Notice and retain or have returned, as the case may be, the shares of Series A Preferred that were to be converted pursuant to such holder’s Conversion Notice (provided that a holder’s voiding its Conversion Notice shall not affect the Company’s obligations to make any payments which have accrued prior to the date of such notice); or
 
(iii) exercise its Buy-In rights pursuant to and in accordance with the terms and provisions of Section 5(c)(viii) hereof.
 
(b)  Mechanics of Fulfilling Holder’s Election . The Company shall promptly send via facsimile to a holder of Series A Preferred, upon receipt of a facsimile copy of a Conversion Notice from such holder which cannot be fully satisfied as described in Section 7(a) above, a notice of the Company’s inability to fully satisfy such holder’s Conversion Notice (the “ Inability to Fully Convert Notice ”). Such Inability to Fully Convert Notice shall indicate (i) the reason why the Company is unable to fully satisfy such holder’s Conversion Notice, and (ii) the number of Series A Preferred that cannot be converted. Such holder shall notify the Company of its election pursuant to Section 7(a) above by delivering written notice via facsimile to the Company (“ Notice in Response to Inability to Convert ”).
 
(c)  Pro-Rata Conversion . In the event the Company receives a Conversion Notice from more than one holder of Series A Preferred on the same day and the Company can convert some, but not all, of the Series A Preferred pursuant to this Section 7, the Company shall convert from each holder of Series A Preferred electing to have Series A Preferred converted at such time an amount equal to such holder’s pro-rata amount (based on the number shares of Series A Preferred held by such holder relative to the number shares of Series A Preferred outstanding) of all shares of Series A Preferred being converted at such time.
 
 
 
-11-
 
 
8.             Redemption .
 
(a)  Redemption Upon Change of Control . Simultaneous with the occurrence of a Change of Control (as defined below), the Company shall be required to redeem all of the outstanding Series A Preferred in cash at a price per share of Series A Preferred equal to 115% of the Liquidation Preference Amount plus all accrued and unpaid dividends after the Cash Dividend Payment Date (the “ Change of Control Redemption Price ”); provided, however , that the Company shall provide holders of shares of Series A Preferred with notice at least ten (10) business days prior to such redemption, and such holders may elect, in their sole discretion, to convert their shares of Series A Preferred, plus any accrued and unpaid dividends after the Cash Dividend Payment Date, into Conversion Shares pursuant to Section 5 prior to the effectiveness of a Change of Control.
 
(b)  “Change of Control” .  A “Change of Control” shall be deemed to have occurred at such time as a third party not affiliated with the Company or any holders of the Series A Preferred shall have acquired, in one or a series of related transactions, equity securities of the Company representing more than 50% of the outstanding voting securities of the Company, and such Change of Control has been approved by the Board.
 
(c)  Mechanics of Redemption Upon Change of Control . Effective upon the consummation of a Change of Control, the Company shall redeem all of the holders’ Series A Preferred then outstanding by delivering written notice thereof via facsimile and overnight courier (“ Notice of Redemption Upon Change of Control ”) to each holder of Series A Preferred, which Notice of Redemption Upon Change of Control shall indicate (i) the number of shares of Series A Preferred that the Company is electing to redeem, and (ii) the Change of Control Redemption Price, as calculated pursuant to Section 8(a) above. The Change of Control Redemption Price shall be paid in cash in accordance with Section 8(a) of this Certificate of Designations. On or prior to the Change of Control, provided that the holders do not elect to convert their shares of Series A Preferred into Conversion Shares pursuant to Section 8(a) above, the holders of Series A Preferred shall surrender to the Company the certificate or certificates representing such shares, in the manner and at the place designated in the Notice of Redemption Upon Change of Control. The Company shall deliver the Change of Control Redemption Price immediately prior to or simultaneously with the consummation of the Change of Control; provided that a holder’s Preferred Stock Certificates shall have been so delivered to the Company (or an indemnification undertaking with respect to such Preferred Stock Certificates in the event of their loss, theft or destruction). From and after the Change of Control transaction, unless there shall have been a default in payment of the Change of Control Redemption Price, all rights of the holders of Series A Preferred as a holder of such Series A Preferred (except the right to receive the Change of Control Redemption Price without interest upon surrender of their certificate or certificates) shall cease with respect to any redeemed shares of Series A Preferred, and such shares shall not thereafter be transferred on the books of the Company or be deemed to be outstanding for any purpose whatsoever. Notwithstanding the foregoing to the contrary, nothing contained herein shall limit a holder’s ability to convert its shares of Series A Preferred following the receipt of the Notice of Redemption Upon Change of Control and prior to the consummation of the Change of Control transaction. 
 
(d)  Company’s Redemption Option .  The Company may redeem all or a portion of the Series A Preferred outstanding upon ten (10) business days’ prior written notice (the “ Company’s Redemption Notice ”) in cash at a price per share of Series A Preferred equal to 115% of the Liquidation Preference Amount plus all accrued and unpaid dividends after the Cash Dividend Payment Date (the “ Company’s Redemption Price ”); provided, however , that if a holder has delivered a Conversion Notice to the Company for all or a portion of the Shares of Series A Preferred, such shares of Series A Preferred designated to be redeemed may be converted by such holder. The Company’s Redemption Notice shall state the date of redemption, which date shall be ten (10) business days after the Company has delivered the Company’s Redemption Notice (the “ Company’s Redemption Date ”), the Company’s Redemption Price and the number of shares to be redeemed by the Company. The Company shall deliver the Company’s Redemption Price to the holder(s) within ten (10) business days after the Company has delivered the Company’s Redemption Notice; provided, however , that if the holder(s) delivers a Conversion Notice before the Company’s Redemption Date, then the portion of the Company’s Redemption Price which would be paid to redeem the shares of Series A Preferred covered by such Conversion Notice shall be returned to the Company upon delivery of the Common Stock issuable in connection with such Conversion Notice to the holder(s). On the Redemption Date, the Company shall pay the Company’s Redemption Price, subject to any adjustment pursuant to the immediately preceding sentence, to the holder(s) on a pro rata basis; provided, however, that upon receipt by the Company of the Preferred Stock Certificates to be redeemed pursuant to this Section 8(d), the Company shall, on the next business day following the date of receipt by the Company of such Preferred Stock Certificates, pay the Company’s Redemption Price, subject to any adjustment pursuant to the immediately preceding sentence, to the holder(s) on a pro rata basis.
 
 
 
-12-
 
 
9.             Registration Rights.
 
(a)  Piggyback Registration .
 
(i) If at any time within two (2) years following the Issuance Date that any shares of Series A Preferred remain outstanding the Company proposes for any reason to register any shares of Common Stock under the Securities Act, (other than pursuant to a registration statement on Form S-4 or Form S-8 (or a similar or successor form)) with respect to an offering of Common Stock by the Company for its own account or for the account of any of its stockholders, it shall, unless a holder of Series A Preferred has provided written notice to the Company that it does not want to receive such information, at each such time promptly give written notice to the holders of the Series A Preferred of its intention to do so (but in no event less than thirty (30) days before the anticipated filing date) and, to the extent permitted under the provisions of Rule 415 under the Securities Act, include in such registration all Conversion Shares issuable upon conversion of the outstanding shares of Series A Preferred (the “ Registerable Securities ”) with respect to which the Company has received written requests for inclusion therein within fifteen (15) days after receipt of the Company’s notice (a “ Piggyback Registration ”). Such notice shall offer the holders of the Registrable Securities the opportunity to register such number of shares of Registrable Securities as each such holder may request and shall indicate the intended method of distribution of such Registrable Securities.
 
(ii) Notwithstanding the foregoing, in the event a holder of Series A Preferred elects to require the Company register shares of Registrable Securities pursuant to Section 9(a)(i) above, (A) if such registration involves an underwritten public offering, the holders must sell their Registrable Securities to, if applicable, the underwriter(s) at the same price and subject to the same underwriting discounts and commissions that apply to the other securities sold in such offering (it being acknowledged that the Company shall be responsible for other expenses) and subject to the holders entering into customary underwriting documentation for selling stockholders in an underwritten public offering, and (B) if, at any time after giving written notice of its intention to register any Registrable Securities pursuant to Section 9(a)(i) and prior to the effective date of the registration statement filed in connection with such registration, the Company shall determine for any reason not to cause such registration statement to become effective under the Securities Act, the Company shall deliver written notice to the holders and, thereupon, shall be relieved of its obligation to register any Registrable Securities in connection with such registration. Any holder may elect to withdraw such holder’s request for inclusion of Registrable Securities in any Piggyback Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness of the registration statement or the pricing of an underwritten offering, as applicable.
 
(b)  Demand Registration .
 
(i) At any time following the two (2) year anniversary of the Issuance Date, holders of the issued and outstanding Series A Preferred (acting together) that own or control Registrable Securities representing at least fifty percent (50%) of the then-issued and outstanding Registrable Securities (collectively, the “ Requesting Holders ”), may deliver to the Company a written notice (a “ Demand Registration Notice ”) informing the Company that such Requesting Holders require the Company to register for resale some or all of such Requesting Holders’ Registrable Securities not otherwise then registered for resale (a “ Demand Registration ”);  provided, however,  that the Company will not be required to effect more than one (1) Demand Registration in accordance with this Certificate of Designations. Upon receipt of the Demand Registration Notice, the Company will use best efforts to file with the SEC as promptly as practicable after receiving the Demand Registration Notice, but in no event more than sixty (60) days following receipt of the Demand Registration Notice, a registration statement covering all requested Registrable Securities (the “ Demand Registration Statement ”), and agrees to use best efforts to cause the Demand Registration Statement to be declared effective by the SEC as soon as practicable following the filing thereof, but in no event later than ninety (90) days after the filing of such Demand Registration Statement. The Company agrees to use best efforts to keep any Demand Registration Statement continuously effective (including the preparation and filing of any amendments and supplements necessary for that purpose) until such time as all of the Registrable Securities covered thereby have been sold (“ Minimum Effective Period ”).
 
 
-13-
 
 
(ii)  Notice to Holders . The Company shall give written notice of the proposed filing of any Demand Registration Statement to all holders of issued and outstanding shares of Series A Preferred (other than the Requesting Holders) as soon as practicable, and each such holder who wishes to participate in such Demand Registration Statement shall notify the Company in writing within five (5) business days after the receipt by such holder of the notice from the Company, and shall specify in such notice the number of Registrable Securities held by such holder to be included in the Demand Registration Statement. Upon the written request of any holder, delivered to the Company no later than five (5) business days after the Company’s notice is delivered to such holder, to register, on the same terms and conditions as the Registrable Securities otherwise being sold pursuant to such Demand Registration, any of its Registrable Securities, the Company will use its best efforts to cause such Registrable Securities to be included in the Demand Registration Statement proposed to be filed by the Company on the same terms and conditions as any Registrable Securities included therein.
 
10.             Lost or Stolen Certificates . Upon receipt by the Company of evidence satisfactory to the Company of the loss, theft, destruction or mutilation of any Preferred Stock Certificates representing the shares of Series A Preferred, and, in the case of loss, theft or destruction, of an indemnification undertaking by the holder to the Company (in form and substance satisfactory to the Company) and, in the case of mutilation, upon surrender and cancellation of the Preferred Stock Certificate(s), the Company shall execute and deliver new Preferred Stock Certificate(s) of like tenor and date; provided, however , the Company shall not be obligated to re-issue Preferred Stock Certificates if the holder contemporaneously requests the Company to convert such shares of Series A Preferred into Common Stock.
 
11.             Governing Law . All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designations shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflict of laws thereof.
 
12.             Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief . The remedies provided in this Certificate of Designations shall be cumulative and in addition to all other remedies available under this Certificate of Designations, at law or in equity (including a decree of specific performance and/or other injunctive relief), no remedy contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy and nothing herein shall limit a holder’s right to pursue actual damages for any failure by the Company to comply with the terms of this Certificate of Designations. Amounts set forth or provided for herein with respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by the holder thereof and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the holders of the Series A Preferred and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach, the holders of the Series A Preferred shall be entitled, in addition to all other available remedies, to an injunction restraining any breach or the Series A Preferred stockholders’ reasonable perception of a threatened breach by the Company of the provisions of this Certificate of Designations, without the necessity of showing economic loss and without any bond or other security being required.
 
13.             Specific Shall Not Limit General; Construction . No specific provision contained in this Certificate of Designations shall limit or modify any more general provision contained herein. This Certificate of Designations shall be deemed to be jointly drafted by the Company and all initial purchasers of the Series A Preferred and shall not be construed against any person as the drafter hereof.
 
14.           Failure or Indulgence Not Waiver . No failure or delay on the part of a holder of Series A Preferred in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege.
 
 
 
-14-
 
 
IN WITNESS WHEREOF,  this Certificate of Designations is executed on Company this 13th day of November 2018.
 
 
 
 
 FITLIFE BRANDS, INC.
 
 
 
By:  /s/ Michael Abrams
Name:  Michael Abrams
Title:   Chief Financial Officer
 
 
 
-15-
 
 
EXHIBIT A
FITLIFE BRANDS, INC. CONVERSION NOTICE
 
Reference is made to the Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock of FitLife Brands, Inc. (the “ Certificate of Designation ”).   In accordance with and pursuant to the Certificate of Designation, the undersigned hereby elects to convert the number of shares of Series A Preferred, par value $0.01 per share (the “ Preferred Shares ”), of FitLife Brands, Inc., a Nevada corporation (the “ Company ”),   indicated below into shares of Common Stock, par value $0.01 per share (the “ Common Stock ”),   of the Company, by tendering the stock certificate(s) representing the share(s) of Preferred Shares specified below as of the date specified below.
 
 
Date of Conversion:   
 
Number of Preferred Shares to be converted:
 
Stock certificate no(s). of Preferred Shares to be converted:
 
Number of Preferred Shares to be converted:
 
Please confirm the following information:
 
Conversion Price:
 
Number of shares of Common Stock to be issued:
 
Number of shares of Common Stock beneficially owned or deemed beneficially owned by the Holder on the Date of Conversion determined in accordance with Section 16 of the Securities Exchange Act of 1934, as amended: 
 
Please issue the Common Stock into which the Preferred Shares are being converted and, if applicable, any check drawn on an account of the Company in the following name and to the following address:
 
Issue to:  
 
Facsimile Number:
 
Name of bank/broker due to receive the underlying Common Stock:
 
Bank/broker's four digit “DTC” participant number (obtained from the receiving bank/broker):
 
Authorization:  
 
By:            
Title:         
Dated:      
 
 
 
A-1
 
Exhibit 4.1
 
Warrant Certificate No. ______
 
THE SECURITIES REPRESENTED HEREBY H AVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED, OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS AND THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR APPLICABLE STATE SECURITIES LAWS.   HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.
 
Effective Date: November ___, 2018Expiration Date: November ___, 2023 1
Warrant No. ________
 
FITLIFE BRANDS, INC.
 
WARRANT TO PURCHASE COMMON STOCK
 
FitLife Brands, Inc. ,   a Nevada corporation (the “ Company ”), for value received on the Effective Date, hereby issues to __________________________ (the “ Holder ”) this Warrant (the “ Warrant ”) to purchase ______________ shares (as from time to time adjusted as hereinafter provided) (each such share a “ Warrant Share ” and all such shares being the “ Warrant Shares ”) of the Company’s Common Stock (as defined below), at the Exercise Price (as defined below), as adjusted from time to time as provided herein, on or before the Expiration Date, all subject to the following terms and conditions.
 
As used in this Warrant, (i) “ Business Day ” means any day other than Saturday, Sunday or any other day on which commercial banks in the City of New York, New York, are authorized or required by law or executive order to close; (ii) “ Common Stock ” means the common stock of the Company, par value $0.01 per share, including any securities issued or issuable with respect thereto or into which or for which such shares may be exchanged for, or converted into, pursuant to any stock dividend, stock split, stock combination, recapitalization, reclassification, reorganization or other similar event; (iii) “ Exercise Price ” means $_____ 2 per share of Common Stock, subject to adjustment as provided herein; (iv) “ Trading Day ” means any day on which the primary national or regional stock exchange on which the Common Stock is listed, or if not so listed, the OTC Bulletin Board or the OTC Markets, if quoted thereon,   is open for the transaction of business; and (v) “ Affiliate ” means any person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, a person, as such terms are used and construed in Rule 144 promulgated under the Securities Act of 1933, as amended (the “ Securities Act ”).
 
 
1   The Warrant shall expire 5 years from the date of issuance
2 This amount will be equal to the conversion price of the shares of Series A Preferred purchased by the investor, which is the fair market value of the Company’s Common Stock on the closing date, as reported on the OTC markets
 
 
 
-1-
 
1.  
DURATION AND EXERCISE OF WARRANTS
 
(a)             Exercise Period . The Holder may exercise this Warrant in whole or in part on any Business Day on or before 5:00 P.M., Eastern Time, on the Expiration Date, at which time this Warrant shall become void and of no value.
 
(b)  
Exercise Procedures .
 
(i)             While this Warrant remains outstanding and exercisable in accordance with Section 1(a) , the Holder may exercise this Warrant in whole or in part at any time and from time to time by:
 
(A)             delivery to the Company of a duly completed and executed copy of the notice of exercise attached hereto as Exhibit A (the “ Notice of Exercise ;
 
(B)             surrender of this Warrant to the Secretary of the Company at its principal offices or at such other office or agency as the Company may specify in writing to the Holder; and
 
(C)             payment of the then-applicable Exercise Price per share multiplied by the number of Warrant Shares being purchased upon exercise of the Warrant (such amount, the “ Aggregate Exercise Price ”) made in the form of cash, or by wire transfer of immediately available funds, certified check or bank draft payable in lawful money of the United States of America.
 
 (ii)             Upon the exercise of this Warrant in compliance with the provisions of this Section 1(b), and except as limited pursuant to Section 1(b)(iv), the Company shall promptly issue and cause to be delivered to the Holder a certificate for the Warrant Shares for which this Warrant was exercised. Each exercise of this Warrant shall be effective immediately prior to the close of business on the date (the “ Date of Exercise ”) that the conditions set forth in Section 1(b)(i) or (ii) have been satisfied, as the case may be. On or before the third (3 rd ) Business Day following the date on which the Company has received each of the items specified in Section 1(b)(i) or 1(b)(ii), as applicable (the “ Exercise Deliverables ”), the Company shall transmit an acknowledgment of receipt of the Exercise Deliverables to the Company’s transfer agent (the “ Transfer Agent ”). On or before the fifth (5 th ) Business Day following the date on which the Company has received all of the Exercise Deliverables (the “ Share Delivery Date ”), the Company shall (X) provided that the Warrant Shares have been registered or that the Warrant Shares are eligible for sale under Rule 144 without restriction and that the Transfer Agent is participating in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program, upon the request of the Holder and to the extent applicable, Holder’s supplying the Company with required Rule 144 documentation, cause the Transfer Agent to credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system, or (Y) if the Warrant Shares have not been registered and are not eligible for sale under Rule 144 without restriction or if Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program, cause the Transfer Agent to issue and dispatch by overnight courier to the address as specified in the Notice of Exercise, a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder is entitled pursuant to such exercise.
 
 
-2-
 
Upon delivery of the Exercise Deliverables, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the certificates evidencing such Warrant Shares.
 
(iv)           If the Company shall fail for any reason or for no reason to issue or cause to be issued to the Holder, within five (5) Business Days of receipt of the Exercise Deliverables, a certificate for the number of shares of Common Stock to which the Holder is entitled and register or cause to be registered such shares of Common Stock on the Company’s share register or to credit or cause to be credited the Holder’s balance account with DTC for such number of shares of Common Stock to which the Holder is entitled upon the Holder’s exercise of this Warrant (in each case as provided above), and if on or after such fifth (5 th ) Business Day the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable upon such exercise that the Holder anticipated receiving from the Company (a “ Buy-In ”), then the Company shall, within three (3) Business Days after the Holder’s request and in the Holder’s discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased (the “ Buy-In Price ”), at which point the Company’s obligation to deliver a certificate for the shares of Common Stock to which the Holder would have been entitled and register or cause to be registered such shares of Common Stock on the Company’s share register, or to credit or cause to be credited the Holder’s balance account with DTC for such number of shares of Common Stock to which the Holder would have been entitled, shall terminate, or (ii) promptly honor its obligation to deliver to the Holder a certificate or certificates representing such shares of Common Stock and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of shares of Common Stock, times (B) the fair value of the Common Stock on the date of exercise.
 
(v)             Notwithstanding the foregoing provisions of this Section 1(b), the Holder may not exercise this Warrant if and to the extent that such exercise would require the Company to issue a number of shares of Common Stock in excess of its authorized but unissued shares of Common Stock, less all amounts of Common Stock that have been reserved for issue upon the conversion of all outstanding securities convertible into shares of Common Stock and the exercise of all outstanding options, warrants and other rights exercisable for shares of Common Stock. If the Company does not have the requisite number of authorized but unissued shares of Common Stock to permit the Holder to exercise this Warrant, then the Company shall use commercially reasonable efforts to obtain the necessary stockholder consent to increase the authorized number of shares of Common Stock to permit such Holder to exercise this Warrant pursuant to Section 1(b)(i) or Section 1(b)(ii).
 
(vi)             The delivery by (or on behalf of) the Holder of the Notice of Exercise and the applicable Exercise Price as provided above shall constitute the Holder’s certification to the Company that its representations and warranties contained in the Subscription Agreement, including without limitation the representation and warranty that the Holder is an “accredited investor,” are true and correct as of the exercise date as if remade in their entirety (or, in the case of any transferee Holder that is not a party to the Subscription Agreement, such transferee Holder’s certification to the Company that such representations are true and correct as to such assignee Holder as of the exercise date).
 
(c)             Partial Exercise . This Warrant shall be exercisable, either in its entirety or, from time to time, for part of the number of Warrant Shares referenced by this Warrant; provided, that any such partial exercise must be for an integral number of Warrant Shares. If this Warrant is exercised in part, the Company shall issue, at its expense, a new Warrant, in substantially the form of this Warrant, referencing such reduced number of Warrant Shares that remain subject to this Warrant.
 
 
-3-
 
(d)             Disputes . In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in accordance with Section 14.
 
2.  
ISSUANCE OF WARRANT SHARES
 
(a)             The Company covenants that all Warrant Shares will, upon issuance in accordance with the terms of this Warrant, be (i) duly authorized, fully paid and non-assessable, and (ii) free from all liens, charges and security interests, with the exception of claims arising through the acts or omissions of any Holder and except as arising from applicable Federal and state securities laws.
 
(b)             The Company shall register this Warrant upon records to be maintained by the Company for that purpose in the name of the record holder of such Warrant from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner thereof for the purpose of any exercise thereof, any distribution to the Holder thereof and for all other purposes.
 
(c)             The Company will not, by amendment of its articles of incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all action necessary or appropriate in order to protect the rights of the Holder to exercise this Warrant, or against impairment of such rights.
 
3.  
ADJUSTMENTS OF EXERCISE PRICE, NUMBER AND TYPE OF WARRANT SHARES
 
(a)             General . The Exercise Price and the number of shares purchasable upon the exercise of this Warrant shall be subject to adjustment from time to time upon the occurrence of certain events described in this Section 3(a); provided, however, that notwithstanding the provisions of this Section 3, the Company shall not be required to make any adjustment if and to the extent that such adjustment would require the Company to issue a number of shares of Common Stock in excess of its authorized but unissued shares of Common Stock, less all amounts of Common Stock that have been reserved for issue upon the conversion of all outstanding securities convertible into shares of Common Stock and the exercise of all outstanding options, warrants and other rights exercisable for shares of Common Stock. If the Company does not have the requisite number of authorized but unissued shares of Common Stock to make any adjustment, the Company shall use its commercially reasonable efforts to obtain the necessary stockholder consent to increase the authorized number of shares of Common Stock to make such an adjustment pursuant to this Section 3(a).
 
(i)             Subdivision or Combination of Stock . In case the Company shall at any time subdivide (whether by way of stock dividend, stock split or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision shall be proportionately reduced and the number of Warrant Shares shall be proportionately increased, and conversely, in case the outstanding shares of Common Stock of the Company shall be combined (whether by way of stock combination, reverse stock split or otherwise) into a smaller number of shares, the Exercise Price in effect immediately prior to such combination shall be proportionately increased and the number of Warrant Shares shall be proportionately decreased. The Exercise Price and the Warrant Shares, as so adjusted, shall be readjusted in the same manner upon the happening of any successive event or events described in this Section 3(a)(i).
 
 
-4-
 
(ii)             Dividends in Stock, Property, Reclassification . If at any time, or from time to time, the holders of Common Stock (or any shares of stock or other securities at the time receivable upon the exercise of this Warrant) shall have received or become entitled to receive, without payment therefor:
 
(A)             any shares of stock or other securities that are at any time directly or indirectly convertible into or exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend or other distribution, or
 
(B)             additional stock or other securities or property (including cash) by way of spin-off, split-up, reclassification, combination of shares or similar corporate rearrangement (other than shares of Common Stock issued as a stock split or adjustments in respect of which shall be covered by the terms of Section 3(a)(i) above),
 
then and in each such case, the Exercise Price and the number of Warrant Shares to be obtained upon exercise of this Warrant shall be adjusted proportionately, and the Holder hereof shall, upon the exercise of this Warrant, be entitled to receive, in addition to the number of shares of Common Stock receivable thereupon, and without payment of any additional consideration therefor, the amount of stock and other securities and property (including cash in the cases referred to above) that such Holder would hold on the date of such exercise had such Holder been the holder of record of such Common Stock as of the date on which holders of Common Stock received or became entitled to receive such shares or all other additional stock and other securities and property. The Exercise Price and the Warrant Shares, as so adjusted, shall be readjusted in the same manner upon the happening of any successive event or events described in this Section 3(a)(ii) .
 
 
 
-5-
 
(iii)             Reorganization, Reclassification, Consolidation, Merger or Sale . If any recapitalization, reclassification or reorganization of the capital stock of the Company, or any consolidation or merger of the Company with another corporation or any other entity, or the sale of all or substantially all of its assets or other transaction shall be effected in such a way that holders of Common Stock shall be entitled to receive stock, securities or other assets or property (an “ Organic Change ”), then , as a condition of such Organic Change, lawful and adequate provisions shall be made by the Company whereby the Holder hereof shall thereafter have the right to purchase and receive (in lieu of the shares of the Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented by this Warrant) such shares of stock, securities or other assets or property as may be issued or payable with respect to or in exchange for a number of outstanding shares of such Common Stock equal to the number of shares of such stock immediately theretofore purchasable and receivable assuming the full exercise of the rights represented by this Warrant. In the event of any Organic Change, appropriate provision shall be made by the Company with respect to the rights and interests of the Holder of this Warrant to the end that the provisions hereof (including, without limitation, provisions for adjustments of the Exercise Price and of the number of shares purchasable and receivable upon the exercise of this Warrant) shall thereafter be applicable, in relation to any shares of stock, securities or assets thereafter deliverable upon the exercise hereof. The Company shall not effect any such Organic Change unless, prior to the consummation thereof , the successor corporation or entity (if other than the Company) resulting from such consolidation or merger or the corporation purchasing such assets shall assume by written instrument reasonably satisfactory in form and substance to the Holder executed and mailed or delivered to the registered Holder hereof at the last address of such Holder appearing on the books of the Company, the obligation to deliver to such Holder such shares of stock, securities or assets as, in accordance with the foregoing provisions, such Holder may be entitled to purchase. If there is an Organic Change, then the Company shall cause to be mailed to the Holder at its last address as it shall appear on the books and records of the Company, at least ten (10) calendar days before the effective date of the Organic Change, a notice stating the date on which such Organic Change is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares for securities, cash, or other property delivered upon such Organic Change; provided, however , that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. The Holder is entitled to exercise this Warrant during the 10-day period commencing on the date of such notice to the effective date of the event triggering such notice. In any event, the successor corporation (if other than the Company) resulting from such consolidation or merger or the corporation purchasing such assets shall be deemed to assume such obligation to deliver to such Holder such shares of stock, securities or assets even in the absence of a written instrument assuming such obligation to the extent such assumption occurs by operation of law.
 
(b)             Certificate as to Adjustments . Upon the occurrence of each adjustment or readjustment pursuant to this Section 3, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to each Holder of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall promptly furnish or cause to be furnished to such Holder a like certificate setting forth: (i) such adjustments and readjustments; and (ii) the number of shares and the amount, if any, of other property which at the time would be received upon the exercise of the Warrant.
 
(c)             Certain Events . If any event occurs as to which the other provisions of this Section 3 are not strictly applicable but the lack of any adjustment would not fairly protect the purchase rights of the Holder under this Warrant in accordance with the basic intent and principles of such provisions, or if strictly applicable would not fairly protect the purchase rights of the Holder under this Warrant in accordance with the basic intent and principles of such provisions, then the Company’s Board of Directors will, in good faith and subject to applicable law, make an appropriate adjustment to protect the rights of the Holder; provided, however , that no such adjustment pursuant to this Section 3(d) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this Section 3.
 
 
 
-6-
 
4.  
TRANSFERS AND EXCHANGES OF WARRANT AND WARRANT SHARES
 
(a)             Registration of Transfers and Exchanges . Subject to Section 4(c), upon the Holder’s surrender of this Warrant, with a duly executed copy of the Form of Assignment attached as Exhibit B , to the Secretary of the Company at its principal offices or at such other office or agency as the Company may specify in writing to the Holder, the Company shall register the transfer of all or any portion of this Warrant. Upon such registration of transfer, the Company shall issue a new Warrant, in substantially the form of this Warrant, evidencing the acquisition rights transferred to the transferee and a new Warrant, in similar form, evidencing the remaining acquisition rights not transferred, to the Holder requesting the transfer.
 
(b)             Warrant Exchangeable for Different Denominations . The Holder may exchange this Warrant for a new Warrant or Warrants, in substantially the form of this Warrant, evidencing in the aggregate the right to purchase the number of Warrant Shares, which may then be purchased hereunder, each of such new Warrants to be dated the date of such exchange and to represent the right to purchase such number of Warrant Shares as shall be designated by the Holder. The Holder shall surrender this Warrant with duly executed instructions regarding such re-certification of this Warrant to the Secretary of the Company at its principal offices or at such other office or agency as the Company may specify in writing to the Holder.
 
(c)             Restrictions on Transfers . This Warrant may not be transferred at any time without (i) registration under the Securities Act or (ii) an exemption from such registration and, if requested by the Company, a written opinion of legal counsel addressed to the Company that the proposed transfer of the Warrant may be effected without registration under the Securities Act, which opinion will be in form and from counsel reasonably satisfactory to the Company.
 
(d)             Permitted Transfers and Assignments . Notwithstanding any provision to the contrary in this Section 4, the Holder may transfer, with or without consideration, this Warrant or any of the Warrant Shares (or a portion thereof) to the Holder’s Affiliates (as such term is defined under Rule 144 of the Securities Act) without obtaining the opinion from counsel that may be required by Section 4(c)(ii), provided , that the Holder delivers to the Company and its counsel certification, documentation, and other assurances reasonably required by the Company’s counsel to enable the Company’s counsel to render an opinion to the Company’s Transfer Agent that such transfer does not violate applicable securities laws.
 
5.  
MUTILATED OR MISSING WARRANT CERTIFICATE
 
If this Warrant is mutilated, lost, stolen or destroyed, upon request by the Holder, the Company will, at its expense, issue, in exchange for and upon cancellation of the mutilated Warrant, or in substitution for the lost, stolen or destroyed Warrant, a new Warrant, in substantially the form of this Warrant, representing the right to acquire the equivalent number of Warrant Shares; provided, however , that, as a prerequisite to the issuance of a substitute Warrant, the Company may require satisfactory evidence of loss, theft or destruction as well as an indemnity from the Holder of a lost, stolen or destroyed Warrant.
 
 
 
 
-7-
 
6.  
PAYMENT OF TAXES
 
The Company will pay all transfer and stock issuance taxes attributable to the preparation, issuance and delivery of this Warrant and the Warrant Shares (and replacement Warrants) including, without limitation, all documentary and stamp taxes; provided, however , that the Company shall not be required to pay any tax in respect of the transfer of this Warrant, or the issuance or delivery of certificates for Warrant Shares or other securities in respect of the Warrant Shares to any person or entity other than to the Holder.
 
7.             
FRACTIONAL SHARES
 
No fractional Warrant Shares shall be issued upon exercise of this Warrant. Upon the full exercise of this Warrant, the Company, in lieu of issuing any fractional Warrant Share, shall round up the number of Warrant Shares issuable to nearest whole share.
 
8.  
NO STOCK RIGHTS AND LEGEND
 
No holder of this Warrant, as such, shall be entitled to vote or be deemed the holder of any other securities of the Company that may at any time be issuable on the exercise hereof, nor shall anything contained herein be construed to confer upon the holder of this Warrant, as such, the rights of a stockholder of the Company or the right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or give or withhold consent to any corporate action or to receive notice of meetings or other actions affecting stockholders (except as provided herein), or to receive dividends or subscription rights or otherwise (except as provide herein).
 
Each certificate for Warrant Shares initially issued upon the exercise of this Warrant, and each certificate for Warrant Shares issued to any subsequent transferee of any such certificate, shall be stamped or otherwise imprinted with a legend in substantially the following form:
 
THE SECURITIES REPRESENTED HEREBY H AVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED, OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS AND THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR APPLICABLE STATE SECURITIES LAWS.   HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.
 
 
 
 
-8-
 
9.  
NOTICES
 
All notices, consents, waivers, and other communications under this Warrant must be in writing and will be deemed given to a party (a) on the date of delivery, if delivered to the appropriate address by hand or by nationally recognized overnight courier service (costs prepaid); (b) the date of transmission if sent by facsimile or e-mail with confirmation of transmission by the transmitting equipment if such notice or communication is delivered prior to 5:00 P.M., New York City time, on a Trading Day, or the next Trading Day after the date of transmission, if such notice or communication is delivered on a day that is not a Trading Day or later than 5:00 P.M., New York City time, on any Trading Day; (c) the date received or rejected by the addressee, if sent by certified mail, return receipt requested, if to the registered Holder hereof; or (d) seven days after the placement of the notice into the mails (first class postage prepaid), to the Holder at the address, facsimile number, or e-mail address furnished by the registered Holder to the Company in accordance with the Subscription Agreement by and between the Company and the Holder or, if the registered Holder is not the original purchaser of this Warrant, then as provided in the Form of Assignment delivered to the Company pursuant to Section 4(a) in connection with the assignment of this Warrant to such Holder, or if to the Company, to it at:
 
FitLife Brands, Inc.
5214 S. 136 th Street
Omaha, Nebraska 68137
Attention: Chief Financial Officer
Facsimile:
Email:
 
 (or to such other address, facsimile number, or e-mail address as the Holder or the Company as a party may designate by notice to the other party in accordance with this Section 9) with a copy to
 
Disclosure Law Group
600 West Broadway, Suite 700
San Diego, CA 92101
Attention: Daniel W. Rumsey
Facsimile: 619-330-2101
Email: drumsey@disclosurelawgroup.com
 
10.  
SEVERABILITY
 
If a court of competent jurisdiction holds any provision of this Warrant invalid or unenforceable, the other provisions of this Warrant will remain in full force and effect. Any provision of this Warrant held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.
 
11.  
BINDING EFFECT
 
This Warrant shall be binding upon and inure to the sole and exclusive benefit of the Company, its successors and assigns, the registered Holder or Holders from time to time of this Warrant and the Warrant Shares.
 
 
 
 
-9-
 
12.  
SURVIVAL OF RIGHTS AND DUTIES
 
This Warrant shall terminate and be of no further force and effect on the earlier of 5:00 P.M., Eastern Time, on the Expiration Date or the date on which this Warrant has been exercised in full.
 
13.  
GOVERNING LAW
 
This Warrant will be governed by and construed under the laws of the State of Nevada without regard to conflicts of laws principles that would require the application of any other law.
 
14.  
DISPUTE RESOLUTION
 
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile within five (5) Business Days of receipt of the Notice of Exercise giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, at its sole discretion, within five (5) Business Days, submit via facsimile (a) the disputed determination of the Exercise Price to an independent, reputable investment bank add same to cod selected by the Company and approved by the Holder, or (b) the disputed arithmetic calculation of the Warrant Shares to the Company’s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives the disputed determinations or calculations; provided that, if such disputed determination or arithmetic calculation being submitted by the Holder is determined to be incorrect, then the expense of the investment bank or the accountant shall be the responsibility of the Holder. Such investment bank’s or accountant’s determination or calculation, as the case may be, shall be final, binding and conclusive upon the parties thereto .
 
15.  
NOTICES OF RECORD DATE
 
Upon (a) any establishment by the Company of a record date of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend or other distribution, or right or option to acquire securities of the Company, or any other right, or (b) any capital reorganization, reclassification, recapitalization, merger or consolidation of the Company with or into any other corporation or other entity, any transfer of all or substantially all the assets of the Company, or any voluntary or involuntary dissolution, liquidation or winding up of the Company, or the sale, in a single transaction, of a majority of the Company’s voting stock (whether newly issued, or from treasury, or previously issued and then outstanding, or any combination thereof), the Company shall mail to the Holder at least ten (10) Business Days, or such longer period as may be required by law, prior to the record date specified therein, a notice specifying (i) the date established as the record date for the purpose of such dividend, distribution, option or right and a description of such dividend, option or right, (ii) the date on which any such reorganization, reclassification, transfer, consolidation, merger, dissolution, liquidation or winding up, or sale is expected to become effective and (iii) the date, if any, fixed as to when the holders of record of Common Stock shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such reorganization, reclassification, transfer, consolation, merger, dissolution, liquidation or winding up.
 
 
 
-10-
 
16.  
RESERVATION OF SHARES
 
The Company shall reserve and keep available out of its authorized but unissued shares of Common Stock for issuance upon the exercise of this Warrant, free from pre-emptive rights, such number of shares of Common Stock for which this Warrant shall from time to time be exercisable. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation. Without limiting the generality of the foregoing, the Company covenants that it will use commercially reasonable efforts to take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and use commercially reasonable efforts to obtain all such authorizations, exemptions or consents, including but not limited to consents from the Company’s stockholders or Board of Directors or any public regulatory body, as may be necessary to enable the Company to perform its obligations under this Warrant.
 
17.  
HEADINGS
 
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.
 
18.  
AMENDMENT AND WAIVERS
 
Any term of this Warrant may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), with the written consent of the Company and the Holders of a majority of the Warrant Shares issuable upon exercise of the Warrants.
 
19.  
NO THIRD PARTY RIGHTS
 
This Warrant is not intended, and will not be construed, to create any rights in any parties other than the Company and the Holder, and no person or entity may assert any rights as third-party beneficiary hereunder.
 
[Signature Page Follows]
 
-11-
 
IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the date first set forth above.
 
FITLIFE BRANDS, INC.
 
By:                                                        
Name:  Michael Abrams
Title:  Chief Financial Officer
 
 
-12-
 
EXHIBIT A
 
NOTICE OF EXERCISE
 
(To be executed by Holder of Warrant if Holder desires to exercise Warrant)
 
To FitLife Brands, Inc.:
 
The undersigned hereby irrevocably elects to exercise this Warrant with respect to ___________________ shares of Common Stock (as defined in the Warrant) as follows :
 
Number of shares of Common Stock exercised X $___ per share = $_________ (to be paid as provided in Section 1(b)(i) of the Warrant) plus any applicable taxes payable by the undersigned pursuant to the Warrant.
 
The undersigned requests that certificates for such shares be issued in the name of:
 
_________________________________________
_________________________________________
_________________________________________
 
(Please print name, address and social security or federal employer identification number (if applicable))*
 
If the shares issuable upon this exercise of the Warrant are not all of the Warrant Shares which the Holder is entitled to acquire upon the exercise of the Warrant, the undersigned requests that a new Warrant evidencing the rights not so exercised be issued in the name of and delivered to:
_________________________________________
_________________________________________
_________________________________________
 
(Please print name, address and social security or federal employer identification number (if applicable))*
 
Name of Holder (print):                                                                                         
(Signature):                                                                                         
(By:)                                                                                         
(Title:)                                                                                         
Dated:                                                                                         
 
 
 
*             
If Warrant Shares are to be issued in any name other than that of the registered Holder of the Warrant, then the Holder must include an opinion of counsel, reasonably satisfactory to the Company, to the effect that such issuance complies with all applicable securities laws.
 
A-1
 
EXHIBIT B
 
FORM OF ASSIGNMENT
 
FOR VALUE RECEIVED, ___________________________________ hereby sells, assigns and transfers to each assignee set forth below all of the rights of the undersigned under the Warrant (as defined in and evidenced by the attached Warrant) to acquire the number of Warrant Shares set opposite the name of such assignee below and in and to the foregoing Warrant with respect to said acquisition rights and the shares issuable upon exercise of the Warrant:
 
Name of Assignee (and social security or federal employer identification number (if applicable))
 
Address
 
Number of Shares
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If the total of the Warrant Shares are not all of the Warrant Shares evidenced by the foregoing Warrant, the undersigned requests that a new Warrant evidencing the right to acquire the Warrant Shares not so assigned be issued in the name of and delivered to the undersigned.
 
Name of Holder (print):                                                                                         
(Signature):                                                                                         
(By:)                                                                                         
(Title:)                                                                                         
Dated:                                                                                         
 
 
B-1
 
Exhibit 10.1
 
SUBSCRIPTION AGREEMENT
 
 
 
TO:                 FitLife Brands, Inc. (the “ Company ”)
 
RE:                 Purchase of Securities of FitLife Brands, Inc.
 
Instructions:  
Complete and sign this Subscription Agreement. Please be sure to initial the appropriate “accredited investor” category in Box C.
 
A completed and originally executed copy of, and the other documents required to be delivered with, this Subscription Agreement, must be delivered to the following address:
 
Michael Abrams
Chief Financial Officer
FitLife Brands, Inc.
5214 S. 136 th Street
Omaha, Nebraska 68137
(402) 333-5260
mabrams@fitlifebrands.com
 
1.   The undersigned (the “ Subscriber ”) hereby irrevocably subscribes for and agrees to purchase from the Company the number of units of the Company (“ Units ”) at the price and for the aggregate consideration set forth in Box A of Section 6 below (the “ Subscription Price ”). Each Unit shall have a purchase price of $1,000 per Unit, and will consist of one share of the Company’s Series A Convertible Preferred stock, par value $0.01 per share (“ Series A Preferred ”) (a “ Share ”) and a warrant to purchase that number of shares of Company common stock, par value $0.01 per share (“ Common Stock ”), equal to 30% of the shares of Common Stock issuable upon conversion of the Series A Preferred purchased by the Subscriber (the “ Conversion Shares ”), provided that no warrant will be exercisable for a fractional share (each warrant to purchase shares of Common Stock, a “ Warrant ”). Any Warrant to purchase fractional shares to which a purchaser may otherwise be entitled shall be rounded down to the nearest whole share. The Subscriber acknowledges that this Subscription Agreement is subject to acceptance by the Company. The Company may also accept this Subscription Agreement in part. The Subscriber agrees that if this Subscription Agreement is not accepted in full, any funds related to the portion of this Subscription Agreement not accepted will be returned to the undersigned, without interest.
 
2.   By executing this Subscription Agreement, the Subscriber represents, warrants and covenants (on its own behalf and, if applicable, on behalf of each beneficial purchaser for whom it is contracting hereunder) to the Company (and acknowledges that the Company is relying thereon) that:
 
(a)
it is authorized to consummate the purchase of the Units;
 
(b)
it understands that the Shares, Conversion Shares, Warrants and the shares of Common Stock issuable upon exercise of the Warrants (collectively, the “ Securities ”) have not been, and may never be, registered under the Securities Act of 1933, as amended (the “ Securities Act ”), or any applicable state securities laws, and that the offer and sale of Shares and Warrants to it is being made in reliance on a private placement exemption available under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D under the Securities Act (“ Regulation D ”) to accredited investors (“ Accredited Investors ”), as defined in Rule 501(a) of Regulation D;
 
(c)
it has had access to such information, if any, concerning the Company as it has considered necessary in connection with its investment decision to acquire the Units, and it acknowledges that it has been offered the opportunity to ask questions and receive answers from management of the Company concerning the terms and conditions of the offering of the Units, and to obtain any information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to verify the accuracy of the information contained in the Company’s filings with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”) (the “ Public Filings ”);
 
 
-1-
 
(d)
it has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of its investment in the Units and is able to bear the economic risks of, and withstand the complete loss of, such investment;
 
(e)
it is relying on the information contained in the Public Filings in making its investment decision with respect to the Units. It acknowledges that the Company has not made any representations or given any information to it with respect to the Company or the offer or sale of the Units other than the information contained in the Public Filings;
 
(f)
it is an Accredited Investor acquiring the Units for its own account or, if the Units are to be purchased for one or more accounts (“investor accounts”) with respect to whom it is exercising sole investment discretion, each such investor account is an Accredited Investor on a like basis. In each case, the undersigned has completed Box C of Section 6 to indicate under which category of Rule 501(a) the investor qualifies as an Accredited Investor;
 
(g)
it is not acquiring the Units with a view to any resale, distribution or other disposition of the Units in violation of federal or applicable state securities laws, and, in particular, it has no intention to distribute either directly or indirectly any of the Units in the U.S. or to U.S. persons; provided, however, that the holder may sell or otherwise dispose of any of the Units pursuant to registration thereof under the Securities Act and any applicable state securities laws or pursuant to an exemption from such registration requirements;
 
(h)
in the case of the purchase by the Subscriber of the Units as agent or trustee for any other person, the Subscriber has due and proper authority to act as agent or trustee for and on behalf of such beneficial purchaser in connection with the transactions contemplated hereby;
 
(i)
it is not purchasing the Units as a result of any general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act), including advertisements, articles, notices or other communications published in any newspaper, magazine or similar media or broadcast over radio or television, or any seminar or meeting whose attendees have been invited by general solicitation or general advertising;
 
(j)
it understands that the Securities are “restricted securities” as defined in Rule 144(a)(3) under the Securities Act and agrees that if it decides to offer, sell or otherwise transfer the Securities, such Securities may be offered, sold or otherwise transferred only (A) to the Company, (B) outside the U.S. in accordance with Rule 904 of Regulation S under the Securities Act, (C) within the U.S. or to or for the account or benefit of a U.S. Person in accordance with an exemption from the registration requirements of the Securities Act and all applicable state securities laws, (D) in a transaction that does not require registration under the Securities Act or any applicable U.S. state securities laws or (E) pursuant to an effective registration statement under the Securities Act, and in each case in accordance with any applicable state securities laws in the U.S. or securities laws of any other applicable jurisdiction; provided that with respect to sales or transfers under clauses (C) or (D), only if the holder has furnished to the Company a written opinion of counsel, reasonably satisfactory to the Company, prior to such sale or transfer;
 
(k)
it has been independently advised as to the applicable holding period and resale restrictions with respect to trading imposed in respect of the Securities, by securities legislation in the jurisdiction in which it resides or to which it is otherwise subject, and confirms that no representation has been made respecting the applicable holding periods for the Securities and is aware of the risks and other characteristics of the Securities and of the fact that the undersigned may not be able to resell the Securities except in accordance with applicable securities legislation and regulations;
 
(l)
no person has made to the Subscriber any written or oral representations:
 
(i)
that any person will resell or repurchase any of the Securities;
 
(ii)
that any person will refund the purchase price of the Securities; or
 
(iii)
as to the future price or value of any of the Securities;
 
 
 
-2-
 
(m)
it understands and acknowledges that certificates representing the Shares and the Warrants shall bear the following legend:
 
THE SECURITIES REPRESENTED HEREBY H AVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED, OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS AND THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR APPLICABLE STATE SECURITIES LAWS.   HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.
 
(n)
it consents to the Company making a notation on its records or giving instructions to any transfer agent of the Shares in order to implement the restrictions on transfer set forth and described herein;
 
(o)
the office or other address of the undersigned at which the undersigned received and accepted the offer to purchase the Units is the address listed in Box B of Section 6 below;
 
(p)
if required by applicable securities laws, regulations, rule or order or by any securities commission, stock exchange or other regulatory authority, it will execute, deliver and file, within the approved time periods, all documentation as may be required thereunder, and otherwise assist the Company in filing reports, questionnaires, undertakings and other documents with respect to the issuance of the Units;
 
(q)
this subscription agreement has been duly and validly authorized, executed and delivered by and constitutes a legal, valid, binding and enforceable obligation of the Subscriber; and
 
(r)
it is not an affiliate (as defined in Rule 144 under the Securities Act) of the Company and is not acting on behalf of an affiliate of the Company.
 
3.   The Subscriber acknowledges that the representations and warranties and agreements contained herein are made by it with the intention that they may be relied upon by the Company and its legal counsel in determining its eligibility or, if applicable, the eligibility of others on whose behalf it is contracting hereunder, to purchase the Units. The Subscriber further agrees that by accepting delivery of the Units or by having its agent accept delivery of the Units on its behalf, it shall be representing and warranting that the representations, warranties, acknowledgements and agreements contained herein are true and correct as at the time of accepting delivery of the Units with the same force and effect as if they had been made by the Subscriber at such time and that the representations and warranties shall survive the purchase by the Subscriber of the Units and shall continue in full force and effect notwithstanding any subsequent disposition by the Subscriber of the Units. The Company and its directors, officers, employees, shareholders and its legal counsel shall be entitled to rely on the representations and warranties of the Subscriber contained in this subscription agreement, and the Subscriber shall indemnify and hold harmless the Company and/or its legal counsel for any loss, costs or damages any of them may suffer as a result of any misrepresentations or any breach or failure to comply with any agreement herein.
 
4.   The contract arising out of the acceptance of this subscription by the Company shall be governed by and construed in accordance with the laws of the State of Nebraska and represents the entire agreement of the parties hereto relating to the subject matter hereof.
 
5.   The Company shall be entitled to rely on delivery of a facsimile copy of this Subscription Agreement, and acceptance by the Company of a facsimile copy of this Subscription Agreement shall create a legal, valid and binding agreement among the undersigned and the Company in accordance with the terms hereof.
 
 
 
-3-
 
 
 
6.   SUBSCRIPTION PARTICULARS
 
BOX A
 
Particulars of Purchase of Units
 
 
Number of Units subscribed for:
 
 
 
 
 
 
 
Subscription Price ($____ X number of Units
 
 
 
 
 
 
 
BOX B
 
Subscriber Information
 
 
Name
 
 
 
 
 
 
 
Street Address
 
 
 
 
 
 
 
Street Address (2)
 
 
 
 
 
 
 
City and State
 
 
 
 
 
 
 
Zip Code
 
 
 
 
 
 
 
Contact Name
 
 
 
 
 
 
 
Alternate Contact
 
 
 
 
 
 
 
Phone No.
 
 
 
 
 
 
 
Fax No. / E-mail Address
 
 
 
 
 
 
 
 
-4-
 
BOX C
 
Accredited Investor Status
 
The Subscriber represents and warrants that it is an “accredited investor,” as defined in Rule 501(a) under the Securities Act, by virtue of satisfying one or more of the categories indicated below (please write your initials on the line next to each applicable category) :
 
 
 
 
 
Category 1.
 
A bank, as defined in section 3(a)(2) of the Securities Act.
A savings and loan association or other institution, as defined in section 3(a)(5)(A) of the Securities Act, whether acting in its individual or fiduciary capacity.
A broker or dealer registered pursuant to section 15 of the Exchange Act.
An insurance company as defined in section 2(a)(13) of the Securities Act.
An investment company registered under the Investment Corporation Act of 1940 or a business development company as defined in section 2(a)(48) of that Act.
A Small Business Investment Corporation licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small Business Investment Act of 1958.
A plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000.
An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision is made by a plan fiduciary, as defined in section 3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors.
 
 
Category 2.
 
Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940.
 
 
Category 3.
 
An organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation, a Massachusetts or similar business trust, or a partnership, not formed for the specific purpose of acquiring the Shares, with total assets in excess of $5,000,000.
 
 
Category 4.
 
A director or executive officer of the Company.
 
 
Category 5.
 
A natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of this purchase exceeds $1,000,000, excluding the value of the person’s primary residence, if any.
 
 
Category 6.
 
A natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year.
 
 
Category 7.
 
A trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Shares, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii) of Regulation D under the U.S. Securities Act.
 
 
Category 8.
 
An entity in which each of the equity owners is an accredited investor.
 
7.   A certified check or bank draft in the amount of the Subscription Price as set forth in Box A of Section 6 above, accompanies this Subscription Agreement.
 
SIGNATURE OF SUBSCRIBER
 
Signature of Subscriber (on its own behalf and, if applicable, on behalf of each person for whom it is contracting hereunder):
 
 
 
 
 
 
(Full Name of Subscriber)
 
 
 
 
(Authorized Signature)
 
 
 
 
(Name and Official Capacity – PLEASE PRINT)
 
 
 
-5-
 
 
 
ACCEPTANCE BY COMPANY
 
The Company hereby accepts the above subscription as of this ______ day of November, 2018.
 
FitLife Brands, Inc.
 
 
 
 
(Signature)
 
 
 
 
Michael Abrams, Chief Financial Officer
 
 
 
 
 
-6-
 
Exhibit 31.1
 
Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and pursuant to Rule 13a-14(a) and Rule 15d-14 under the Securities Exchange Act of 1934
 
I, Dayton Judd, Chief Executive Officer of the Company, certify that:
 
1.
I have reviewed this Quarterly Report on Form 10-Q of FitLife Brands, Inc.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c.
Evaluated the effectiveness of the registrant’s disclosure and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations: and
 
 
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
 
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 Registrant
 
Date: November 14, 2018
 
FitLife Brands, Inc.
 
By: /s/ Dayton Judd
 
 
 
Dayton Judd
 
 
 
Chief Executive Officer and Director
(Principal Executive Officer)
 
 
 
 
Exhibit 31.2
 
Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and pursuant to Rule 13a-14(a) and Rule 15d-14 under the Securities Exchange Act of 1934
 
I, Michael Abrams, Chief Financial Officer of the Company, certify that:
 
1.
I have reviewed this Quarterly Report on Form 10-Q of FitLife Brands, Inc.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c.
Evaluated the effectiveness of the registrant’s disclosure and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations: and
 
 
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
 
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
  
Registrant
 
Date: November 14, 2018
 
FitLife Brands, Inc.
 
By: /s/ Michael Abrams
 
 
 
Michael Abrams
 
 
 
Chief Financial Officer and Director
(Principal Financial Officer)
 
 
 
 
  Exhibit 32.1
 
CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
 
In connection with the Quarterly Report of FitLife Brands, Inc. (the " Company ") on Form 10-Q for the period ending September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the " Report "), I, Dayton Judd, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
 
Registrant
 
Date:  November 14, 2018
 
FitLife Brands, Inc.
 
By: /s/ Dayton Judd
 
 
 
Dayton Judd
 
 
 
Chief Executive Officer and Director
(Principal Executive Officer)
 
 
 
 
 
 
Exhibit 32.2
 
CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
 
In connection with the Quarterly Report of FitLife Brands, Inc. (the " Company ") on Form 10-Q for the period ending September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the " Report "), I, Michael Abrams, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
 
Registrant
 
Date: November 14, 2018
 
FitLife Brands, Inc.
 
By: /s/ Michael Abrams
 
 
 
Michael Abrams
 
 
 
Chief Financial Officer and Director
(Principal Financial Officer)